CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: nitroguanidine
Accession: CHEBI:39179
browse the term
Definition: An N-nitro compound that is guanidine in which one of the hydrogens is replaced by a nitro group. It can exist in distinct tautomeric forms, as 1-nitroguanidine (a nitroimine) or 2-nitroguanidine (a nitroamine); in both solid and in solution, the nitroimine form predominates.
Synonyms: related_synonym: Formula=CH4N4O2; picrite
xref: CAS:556-88-7; Wikipedia:Nitroguanidine
G
ALPL
alkaline phosphatase, biomineralization associated
multiple interactions increases activity
ISO
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of ALPL protein] Thiamethoxam results in increased activity of ALPL protein
CTD
PMID:30621503
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
G
ANXA10
annexin A10
increases expression
EXP
Thiamethoxam results in increased expression of ANXA10 mRNA
CTD
PMID:32194361
NCBI chr 4:168,092,537...168,187,736
Ensembl chr 4:168,092,537...168,187,736
G
AR
androgen receptor
affects binding
EXP
Thiamethoxam binds to AR protein
CTD
PMID:31550567
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ARG1
arginase 1
decreases expression
EXP
Thiamethoxam results in decreased expression of ARG1 mRNA
CTD
PMID:32194361
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ATF3
activating transcription factor 3
increases expression
ISO
Thiamethoxam results in increased expression of ATF3 mRNA
CTD
PMID:33533595
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
ISO
Thiamethoxam results in increased expression of BAX protein
CTD
PMID:33533595
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
decreases expression
ISO
Thiamethoxam results in decreased expression of BCL2 protein
CTD
PMID:33533595
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL6
BCL6 transcription repressor
decreases expression
ISO
Thiamethoxam results in decreased expression of BCL6 mRNA
CTD
PMID:33533595
NCBI chr 3:187,721,377...187,745,468
Ensembl chr 3:187,721,377...187,745,725
G
BTG1
BTG anti-proliferation factor 1
increases expression
ISO
Thiamethoxam results in increased expression of BTG1 mRNA
CTD
PMID:33533595
NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
G
CASP3
caspase 3
increases cleavage
ISO
Thiamethoxam results in increased cleavage of CASP3 protein
CTD
PMID:33533595
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CAT
catalase
increases expression decreases expression multiple interactions decreases activity
ISO
Thiamethoxam results in increased expression of CAT mRNA Thiamethoxam results in decreased expression of CAT mRNA [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of CAT mRNA]
CTD
PMID:30621503 PMID:33533595 PMID:34181816 PMID:36958429
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL2
C-C motif chemokine ligand 2
increases expression
ISO
Thiamethoxam results in increased expression of CCL2 mRNA
CTD
PMID:33533595
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO
Thiamethoxam results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein]
CTD
PMID:16981889
NCBI chr 1:154,567,778...154,580,013
Ensembl chr 1:154,567,778...154,580,013
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
ISO
Thiamethoxam results in increased expression of CXCL5 mRNA
CTD
PMID:33533595
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
multiple interactions decreases expression
ISO
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP11A1 mRNA]
CTD
PMID:34181816
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
multiple interactions decreases expression
ISO
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP17A1 mRNA]
CTD
PMID:34181816
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
increases activity increases expression multiple interactions
EXP ISO
Thiamethoxam results in increased activity of CYP19A1 protein Thiamethoxam results in increased expression of CYP19A1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of CYP19A1 mRNA]
CTD
PMID:26464060 PMID:28750898 PMID:34181816
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
decreases expression
EXP
Thiamethoxam results in decreased expression of CYP2C19 protein
CTD
PMID:32194361
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
multiple interactions
EXP
[NADP co-treated with CYP3A4 protein] results in increased activity of Thiamethoxam
CTD
PMID:16153789
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP3A7
cytochrome P450 family 3 subfamily A member 7
multiple interactions increases expression
EXP
Estriol inhibits the reaction [Thiamethoxam results in increased expression of CYP3A7]
CTD
PMID:28750898
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
Thiamethoxam results in decreased expression of CYP7A1 protein
CTD
PMID:32194361
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
DDIT3
DNA damage inducible transcript 3
increases expression
ISO
Thiamethoxam results in increased expression of DDIT3 mRNA; Thiamethoxam results in increased expression of DDIT3 protein
CTD
PMID:33533595
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
ESR1
estrogen receptor 1
affects binding decreases expression
EXP ISO
Thiamethoxam binds to ESR1 protein Thiamethoxam results in decreased expression of ESR1 protein
CTD
PMID:31550567 PMID:33533595
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
FOXO3
forkhead box O3
increases expression
ISO
Thiamethoxam results in increased expression of FOXO3 mRNA
CTD
PMID:33533595
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
G
FSHR
follicle stimulating hormone receptor
decreases expression
ISO
Thiamethoxam results in decreased expression of FSHR protein
CTD
PMID:33533595
NCBI chr 2:48,962,157...49,154,515
Ensembl chr 2:48,962,157...49,154,527
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Thiamethoxam results in decreased expression of G6PC1 mRNA
CTD
PMID:32194361
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
GADD45B
growth arrest and DNA damage inducible beta
decreases expression
ISO
Thiamethoxam results in decreased expression of GADD45B mRNA
CTD
PMID:33533595
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GOT1
glutamic-oxaloacetic transaminase 1
increases activity multiple interactions
ISO
Thiamethoxam results in increased activity of GOT1 protein [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GOT1 protein]
CTD
PMID:30621503
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
GPT
glutamic--pyruvic transaminase
decreases activity
ISO
Thiamethoxam results in decreased activity of GPT protein
CTD
PMID:29197058
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX1
glutathione peroxidase 1
increases expression decreases expression multiple interactions decreases activity
ISO
Thiamethoxam results in increased expression of GPX1 mRNA Thiamethoxam results in decreased expression of GPX1 mRNA [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GPX1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of GPX1 mRNA]
CTD
PMID:30621503 PMID:33533595 PMID:36958429
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
HSD3B1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression multiple interactions
ISO
Thiamethoxam results in decreased expression of HSD3B1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of HSD3B1 mRNA]
CTD
PMID:34181816
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
Thiamethoxam results in increased expression of HSPA5 mRNA; Thiamethoxam results in increased expression of HSPA5 protein
CTD
PMID:33533595
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
IL1B
interleukin 1 beta
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL1B protein] Thiamethoxam results in increased expression of IL1B mRNA; Thiamethoxam results in increased expression of IL1B protein
CTD
PMID:36958429
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
increases expression multiple interactions
ISO
Thiamethoxam results in increased expression of IL6 mRNA Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL6 mRNA]
CTD
PMID:36958429
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
decreases expression
ISO
Thiamethoxam results in decreased expression of ITPR1 mRNA
CTD
PMID:33533595
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
Thiamethoxam results in decreased expression of JUNB mRNA
CTD
PMID:33533595
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
G
LDHA
lactate dehydrogenase A
multiple interactions increases activity
ISO
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of LDHA protein] Thiamethoxam results in increased activity of LDHA protein
CTD
PMID:30621503
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
G
LHCGR
luteinizing hormone/choriogonadotropin receptor
decreases expression multiple interactions increases expression
ISO
Thiamethoxam results in decreased expression of LHCGR protein Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of LHCGR mRNA]
CTD
PMID:33533595 PMID:34181816
NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
G
LST1
leukocyte specific transcript 1
increases expression
ISO
Thiamethoxam results in increased expression of LST1 mRNA
CTD
PMID:33533595
NCBI chr 6:31,586,277...31,588,909
Ensembl chr 6:31,586,124...31,588,909
G
MC4R
melanocortin 4 receptor
decreases expression
ISO
Thiamethoxam results in decreased expression of MC4R mRNA
CTD
PMID:33533595
NCBI chr18:60,371,062...60,372,775
Ensembl chr18:60,371,062...60,372,775
G
MMP7
matrix metallopeptidase 7
increases expression
ISO
Thiamethoxam results in increased expression of MMP7 mRNA
CTD
PMID:33533595
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
NOS2
nitric oxide synthase 2
multiple interactions increases expression decreases activity
ISO
[Thiamethoxam metabolite results in decreased activity of NOS2 protein] which results in increased chemical synthesis of Formaldehyde Silymarin inhibits the reaction [Thiamethoxam results in increased expression of NOS2 mRNA]
CTD
PMID:29197058 PMID:36958429
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PLCG2
phospholipase C gamma 2
decreases expression
ISO
Thiamethoxam results in decreased expression of PLCG2 mRNA
CTD
PMID:33533595
NCBI chr16:81,779,291...81,962,685
Ensembl chr16:81,779,279...81,962,685
G
PRNP
prion protein (Kanno blood group)
increases expression
ISO
Thiamethoxam results in increased expression of PRNP mRNA
CTD
PMID:33533595
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Thiamethoxam results in decreased expression of PTGS2 mRNA
CTD
PMID:33533595
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTHLH
parathyroid hormone like hormone
decreases expression
ISO
Thiamethoxam results in decreased expression of PTHLH mRNA
CTD
PMID:33533595
NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733
G
PTX3
pentraxin 3
increases expression
ISO
Thiamethoxam results in increased expression of PTX3 mRNA
CTD
PMID:33533595
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
G
S100P
S100 calcium binding protein P
increases expression
EXP
Thiamethoxam results in increased expression of S100P mRNA
CTD
PMID:32194361
NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
G
SCARB1
scavenger receptor class B member 1
decreases expression multiple interactions
ISO
Thiamethoxam results in decreased expression of SCARB1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of SCARB1 mRNA]
CTD
PMID:34181816
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SESN2
sestrin 2
increases expression
ISO
Thiamethoxam results in increased expression of SESN2 mRNA
CTD
PMID:33533595
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
G
SLC22A2
solute carrier family 22 member 2
decreases activity
EXP
Thiamethoxam results in decreased activity of SLC22A2 protein
CTD
PMID:31364238
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
G
SLC7A11
solute carrier family 7 member 11
increases expression
ISO
Thiamethoxam results in increased expression of SLC7A11 mRNA
CTD
PMID:33533595
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SOD1
superoxide dismutase 1
multiple interactions decreases expression decreases activity
ISO
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of SOD1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of SOD1 mRNA]
CTD
PMID:30621503 PMID:36958429
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
STAR
steroidogenic acute regulatory protein
multiple interactions decreases expression
ISO
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of STAR mRNA]
CTD
PMID:34181816
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
G
STC2
stanniocalcin 2
increases expression
ISO
Thiamethoxam results in increased expression of STC2 mRNA
CTD
PMID:33533595
NCBI chr 5:173,314,723...173,328,414
Ensembl chr 5:173,314,723...173,328,447
G
THBS4
thrombospondin 4
decreases expression
ISO
Thiamethoxam results in decreased expression of THBS4 mRNA
CTD
PMID:33533595
NCBI chr 5:79,991,332...80,083,287
Ensembl chr 5:79,991,311...80,083,287
G
THRA
thyroid hormone receptor alpha
affects binding
EXP
Thiamethoxam binds to THRA protein
CTD
PMID:31550567
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
G
TNF
tumor necrosis factor
increases expression multiple interactions
ISO
Thiamethoxam results in increased expression of TNF mRNA; Thiamethoxam results in increased expression of TNF protein Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF mRNA]; Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF protein]
CTD
PMID:36958429
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNNT2
troponin T2, cardiac type
increases secretion multiple interactions
ISO
Thiamethoxam results in increased secretion of TNNT2 protein fenugreek seed meal inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]; Polysaccharides inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]
CTD
PMID:30520268
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
G
ABCA13
ATP binding cassette subfamily A member 13
increases expression
EXP
clothianidin results in increased expression of ABCA13 mRNA
CTD
PMID:31626844
NCBI chr 7:48,171,458...48,647,497
Ensembl chr 7:48,171,458...48,647,497
G
ABCB6
ATP binding cassette subfamily B member 6 (LAN blood group)
decreases expression
EXP
clothianidin results in decreased expression of ABCB6 mRNA
CTD
PMID:29044138
NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,772...219,218,994
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
increases expression
EXP
clothianidin results in increased expression of ABCC1 mRNA
CTD
PMID:31626844
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ABCC3
ATP binding cassette subfamily C member 3
multiple interactions increases expression
ISO
[enilconazole co-treated with clothianidin] results in increased expression of ABCC3 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of ABCC3 mRNA clothianidin results in increased expression of ABCC3 mRNA
CTD
PMID:33426623
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
ABCD2
ATP binding cassette subfamily D member 2
decreases expression
EXP
clothianidin results in decreased expression of ABCD2 mRNA
CTD
PMID:31626844
NCBI chr12:39,531,025...39,619,803
Ensembl chr12:39,550,033...39,619,803
G
ABCD3
ATP binding cassette subfamily D member 3
decreases expression
EXP
clothianidin results in decreased expression of ABCD3 mRNA
CTD
PMID:31626844
NCBI chr 1:94,385,131...94,518,663
Ensembl chr 1:94,418,389...94,518,666
G
ABCG1
ATP binding cassette subfamily G member 1
decreases expression
EXP
clothianidin results in decreased expression of ABCG1 mRNA
CTD
PMID:29044138
NCBI chr21:42,199,689...42,297,244
Ensembl chr21:42,199,689...42,297,244
G
ABHD4
abhydrolase domain containing 4, N-acyl phospholipase B
decreases expression
EXP
clothianidin results in decreased expression of ABHD4 mRNA
CTD
PMID:31626844
NCBI chr14:22,598,300...22,612,963
Ensembl chr14:22,598,290...22,612,963
G
ABI3BP
ABI family member 3 binding protein
decreases expression
EXP
clothianidin results in decreased expression of ABI3BP mRNA
CTD
PMID:31626844
NCBI chr 3:100,749,156...100,993,421
Ensembl chr 3:100,749,156...100,993,515
G
ACHE
acetylcholinesterase (Yt blood group)
decreases expression
ISO
clothianidin results in decreased expression of ACHE mRNA
CTD
PMID:35264496
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ADCY2
adenylate cyclase 2
increases expression
EXP
clothianidin results in increased expression of ADCY2 mRNA
CTD
PMID:31626844
NCBI chr 5:7,396,138...7,830,081
Ensembl chr 5:7,396,138...7,830,081
G
ADCY4
adenylate cyclase 4
decreases expression
EXP
clothianidin results in decreased expression of ADCY4 mRNA
CTD
PMID:29044138
NCBI chr14:24,318,359...24,335,071
Ensembl chr14:24,318,349...24,335,093
G
ADGRB2
adhesion G protein-coupled receptor B2
decreases expression
EXP
clothianidin results in decreased expression of ADGRB2 mRNA
CTD
PMID:31626844
NCBI chr 1:31,727,117...31,764,340
Ensembl chr 1:31,727,117...31,764,893
G
ADGRF5
adhesion G protein-coupled receptor F5
decreases expression
EXP
clothianidin results in decreased expression of ADGRF5 mRNA
CTD
PMID:31626844
NCBI chr 6:46,852,522...46,954,939
Ensembl chr 6:46,852,522...46,954,943
G
ADGRG6
adhesion G protein-coupled receptor G6
decreases expression
EXP
clothianidin results in decreased expression of ADGRG6 mRNA
CTD
PMID:31626844
NCBI chr 6:142,302,007...142,446,261
Ensembl chr 6:142,301,854...142,446,266
G
ADH1A
alcohol dehydrogenase 1A (class I), alpha polypeptide
multiple interactions
EXP
[clothianidin co-treated with enilconazole] results in decreased expression of ADH1A mRNA; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in decreased expression of ADH1A mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of ADH1A mRNA
CTD
PMID:32201337
NCBI chr 4:99,276,369...99,290,985
Ensembl chr 4:99,276,369...99,291,003
G
ADH1B
alcohol dehydrogenase 1B (class I), beta polypeptide
decreases expression
EXP
clothianidin results in decreased expression of ADH1B mRNA
CTD
PMID:31626844
NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401
G
ADRB2
adrenoceptor beta 2
decreases expression
EXP
clothianidin results in decreased expression of ADRB2 mRNA
CTD
PMID:31626844
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
G
AGBL3
AGBL carboxypeptidase 3
increases expression
EXP
clothianidin results in increased expression of AGBL3 mRNA
CTD
PMID:31626844
NCBI chr 7:134,986,508...135,135,778
Ensembl chr 7:134,986,508...135,147,963
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
increases expression multiple interactions
ISO
clothianidin results in increased expression of ALDH1A1 mRNA [enilconazole co-treated with clothianidin] results in increased expression of ALDH1A1 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of ALDH1A1 mRNA
CTD
PMID:33426623
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
ALMS1-IT1
ALMS1 intronic transcript 1
increases expression
EXP
clothianidin results in increased expression of ALMS1-IT1 mRNA
CTD
PMID:29044138
NCBI chr 2:73,457,103...73,459,482
Ensembl chr 2:73,456,764...73,459,482
G
AMZ1
archaelysin family metallopeptidase 1
increases expression
EXP
clothianidin results in increased expression of AMZ1 mRNA
CTD
PMID:31626844
NCBI chr 7:2,679,522...2,765,138
Ensembl chr 7:2,679,522...2,775,500
G
ANK3
ankyrin 3
decreases expression
EXP
clothianidin results in decreased expression of ANK3 mRNA
CTD
PMID:31626844
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
ANKRD37
ankyrin repeat domain 37
decreases expression
EXP
clothianidin results in decreased expression of ANKRD37 mRNA
CTD
PMID:31626844
NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628
G
APLF
aprataxin and PNKP like factor
increases expression
EXP
clothianidin results in increased expression of APLF mRNA
CTD
PMID:31626844
NCBI chr 2:68,467,585...68,580,162
Ensembl chr 2:68,467,572...68,655,862
G
ARHGAP17
Rho GTPase activating protein 17
increases expression
EXP
clothianidin results in increased expression of ARHGAP17 mRNA
CTD
PMID:31626844
NCBI chr16:24,919,389...25,015,369
Ensembl chr16:24,919,389...25,015,666
G
ARHGEF2
Rho/Rac guanine nucleotide exchange factor 2
increases expression
EXP
clothianidin results in increased expression of ARHGEF2 mRNA
CTD
PMID:31626844
NCBI chr 1:155,946,854...155,979,617
Ensembl chr 1:155,946,851...156,007,070
G
ARIH2OS
ARIH2 opposite strand lncRNA
increases expression
EXP
clothianidin results in increased expression of ARIH2OS mRNA
CTD
PMID:31626844
NCBI chr 3:48,917,788...48,919,385
Ensembl chr 3:48,917,782...48,918,823
G
ARL11
ADP ribosylation factor like GTPase 11
increases expression
EXP
clothianidin results in increased expression of ARL11 mRNA
CTD
PMID:31626844
NCBI chr13:49,628,507...49,633,872
Ensembl chr13:49,628,507...49,633,872
G
ARL14
ADP ribosylation factor like GTPase 14
increases expression
EXP
clothianidin results in increased expression of ARL14 mRNA
CTD
PMID:35690182
NCBI chr 3:160,677,160...160,678,448
Ensembl chr 3:160,677,160...160,678,448
G
ARL2-SNX15
ARL2-SNX15 readthrough (NMD candidate)
decreases expression
EXP
clothianidin results in decreased expression of ARL2-SNX15 mRNA
CTD
PMID:31626844
NCBI chr11:65,014,160...65,040,572
Ensembl chr11:65,014,182...65,040,570
G
ARL6
ADP ribosylation factor like GTPase 6
increases expression
EXP
clothianidin results in increased expression of ARL6 mRNA
CTD
PMID:31626844
NCBI chr 3:97,764,521...97,801,242
Ensembl chr 3:97,764,521...97,801,229
G
ASB11
ankyrin repeat and SOCS box containing 11
increases expression
EXP
clothianidin results in increased expression of ASB11 mRNA
CTD
PMID:31626844
NCBI chr X:15,281,697...15,315,640
Ensembl chr X:15,281,697...15,315,640
G
ASPHD1
aspartate beta-hydroxylase domain containing 1
decreases expression
EXP
clothianidin results in decreased expression of ASPHD1 mRNA
CTD
PMID:31626844
NCBI chr16:29,900,363...29,919,864
Ensembl chr16:29,900,375...29,919,864
G
ATP1A2
ATPase Na+/K+ transporting subunit alpha 2
decreases expression
EXP
clothianidin results in decreased expression of ATP1A2 mRNA
CTD
PMID:29044138
NCBI chr 1:160,115,759...160,143,591
Ensembl chr 1:160,115,759...160,143,591
G
ATP23
ATP23 metallopeptidase and ATP synthase assembly factor homolog
increases expression
EXP
clothianidin results in increased expression of XRCC6BP1 mRNA
CTD
PMID:31626844
NCBI chr12:57,941,567...57,959,148
Ensembl chr12:57,906,039...57,959,148
G
ATP2B3
ATPase plasma membrane Ca2+ transporting 3
decreases expression
EXP
clothianidin results in decreased expression of ATP2B3 mRNA
CTD
PMID:29044138
NCBI chr X:153,517,642...153,582,929
Ensembl chr X:153,517,642...153,582,939
G
ATP6V0D2
ATPase H+ transporting V0 subunit d2
increases expression
EXP
clothianidin results in increased expression of ATP6V0D2 mRNA
CTD
PMID:31626844
NCBI chr 8:86,098,910...86,154,225
Ensembl chr 8:85,987,323...86,154,225
G
AWAT1
acyl-CoA wax alcohol acyltransferase 1
increases expression
EXP
clothianidin results in increased expression of AWAT1 mRNA
CTD
PMID:31626844
NCBI chr X:70,234,655...70,240,659
Ensembl chr X:70,234,655...70,240,659
G
AXIN1
axin 1
decreases expression
EXP
clothianidin results in decreased expression of AXIN1 mRNA
CTD
PMID:31626844
NCBI chr16:287,440...352,723
Ensembl chr16:287,440...352,723
G
AZIN2
antizyme inhibitor 2
decreases expression
EXP
clothianidin results in decreased expression of AZIN2 mRNA
CTD
PMID:29044138
NCBI chr 1:33,081,153...33,166,795
Ensembl chr 1:33,081,104...33,123,492
G
BARHL1
BarH like homeobox 1
increases expression
EXP
clothianidin results in increased expression of BARHL1 mRNA
CTD
PMID:31626844
NCBI chr 9:132,582,606...132,590,252
Ensembl chr 9:132,582,606...132,590,252
G
BCR
BCR activator of RhoGEF and GTPase
decreases expression
EXP
clothianidin results in decreased expression of BCR mRNA
CTD
PMID:31626844
NCBI chr22:23,180,509...23,318,037
Ensembl chr22:23,179,704...23,318,037
G
BICD2
BICD cargo adaptor 2
decreases expression
EXP
clothianidin results in decreased expression of BICD2 mRNA
CTD
PMID:31626844
NCBI chr 9:92,711,363...92,764,833
Ensembl chr 9:92,711,363...92,764,833
G
BRICD5
BRICHOS domain containing 5
decreases expression
EXP
clothianidin results in decreased expression of BRICD5 mRNA
CTD
PMID:29044138
NCBI chr16:2,209,253...2,210,863
Ensembl chr16:2,209,253...2,210,905
G
C15orf32
chromosome 15 putative open reading frame 32
decreases expression
EXP
clothianidin results in decreased expression of C15ORF32 mRNA
CTD
PMID:31626844
NCBI chr15:92,471,677...92,501,117
Ensembl chr15:92,471,654...92,501,117
G
C16orf74
chromosome 16 open reading frame 74
decreases expression
EXP
clothianidin results in decreased expression of C16ORF74 mRNA
CTD
PMID:31626844
NCBI chr16:85,707,517...85,751,096
Ensembl chr16:85,690,084...85,751,129
G
C21orf140
chromosome 21 open reading frame 140
increases expression
EXP
clothianidin results in increased expression of C21ORF140 mRNA
CTD
PMID:31626844
NCBI chr21:34,400,112...34,401,072
Ensembl chr21:34,400,112...34,401,072
G
C21orf58
chromosome 21 open reading frame 58
decreases expression
EXP
clothianidin results in decreased expression of C21ORF58 mRNA
CTD
PMID:31626844
NCBI chr21:46,300,430...46,323,870
Ensembl chr21:46,300,181...46,323,875
G
C22orf31
chromosome 22 open reading frame 31
decreases expression
EXP
clothianidin results in decreased expression of C22ORF31 mRNA
CTD
PMID:31626844
NCBI chr22:29,058,672...29,073,943
Ensembl chr22:29,058,672...29,061,831
G
C22orf42
chromosome 22 open reading frame 42
decreases expression
EXP
clothianidin results in decreased expression of C22ORF42 mRNA
CTD
PMID:31626844
NCBI chr22:32,149,006...32,160,448
Ensembl chr22:32,149,006...32,159,322
G
C2CD4B
C2 calcium dependent domain containing 4B
increases expression
EXP
clothianidin results in increased expression of C2CD4B mRNA
CTD
PMID:31626844
NCBI chr15:62,163,535...62,165,285
Ensembl chr15:62,163,535...62,165,285
G
C4orf36
chromosome 4 open reading frame 36
decreases expression
EXP
clothianidin results in decreased expression of C4ORF36 mRNA
CTD
PMID:31626844
NCBI chr 4:86,876,205...86,936,204
Ensembl chr 4:86,876,205...86,892,422 Ensembl chr 4:86,876,205...86,892,422
G
C5orf34
chromosome 5 open reading frame 34
increases expression
EXP
clothianidin results in increased expression of C5ORF34 mRNA
CTD
PMID:29044138
NCBI chr 5:43,486,709...43,515,148
Ensembl chr 5:43,486,709...43,515,148
G
C5orf46
chromosome 5 open reading frame 46
increases expression
EXP
clothianidin results in increased expression of C5ORF46 mRNA
CTD
PMID:31626844
NCBI chr 5:147,885,885...147,906,538
Ensembl chr 5:147,880,726...147,906,538
G
CA3
carbonic anhydrase 3
increases expression
EXP
clothianidin results in increased expression of CA3 mRNA
CTD
PMID:31626844
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
G
CACNB2
calcium voltage-gated channel auxiliary subunit beta 2
decreases expression
EXP
clothianidin results in decreased expression of CACNB2 mRNA
CTD
PMID:31626844
NCBI chr10:18,140,424...18,543,557
Ensembl chr10:18,140,424...18,543,557
G
CALHM3
calcium homeostasis modulator 3
increases expression
EXP
clothianidin results in increased expression of CALHM3 mRNA
CTD
PMID:31626844
NCBI chr10:103,472,804...103,479,240
Ensembl chr10:103,472,804...103,479,240
G
CAPN5
calpain 5
increases expression
EXP
clothianidin results in increased expression of CAPN5 mRNA
CTD
PMID:29044138
NCBI chr11:77,066,971...77,126,155
Ensembl chr11:77,066,961...77,126,155
G
CAPS
calcyphosine
decreases expression
EXP
clothianidin results in decreased expression of CAPS mRNA
CTD
PMID:29044138
NCBI chr19:5,914,254...5,916,211
Ensembl chr19:5,912,339...5,916,211
G
CARMIL1
capping protein regulator and myosin 1 linker 1
decreases expression
EXP
clothianidin results in decreased expression of LRRC16A mRNA
CTD
PMID:31626844
NCBI chr 6:25,279,374...25,620,530
Ensembl chr 6:25,279,078...25,620,530
G
CARMIL3
capping protein regulator and myosin 1 linker 3
increases expression
EXP
clothianidin results in increased expression of CARMIL3 mRNA
CTD
PMID:29044138
NCBI chr14:24,052,009...24,069,729
Ensembl chr14:24,052,009...24,069,729
G
CCDC17
coiled-coil domain containing 17
decreases expression
EXP
clothianidin results in decreased expression of CCDC17 mRNA
CTD
PMID:29044138
NCBI chr 1:45,620,044...45,624,054
Ensembl chr 1:45,620,044...45,624,057
G
CCDC8
coiled-coil domain containing 8
increases expression
EXP
clothianidin results in increased expression of CCDC8 mRNA
CTD
PMID:31626844
NCBI chr19:46,410,329...46,413,564
Ensembl chr19:46,410,329...46,413,564
G
CCSER1
coiled-coil serine rich protein 1
decreases expression
EXP
clothianidin results in decreased expression of CCSER1 mRNA
CTD
PMID:31626844
NCBI chr 4:90,127,394...91,605,295
Ensembl chr 4:90,127,394...91,605,295
G
CD226
CD226 molecule
decreases expression
EXP
clothianidin results in decreased expression of CD226 mRNA
CTD
PMID:31626844
NCBI chr18:69,853,274...69,961,773
Ensembl chr18:69,831,158...69,961,803
G
CD34
CD34 molecule
increases expression
EXP
clothianidin results in increased expression of CD34 mRNA
CTD
PMID:31626844
NCBI chr 1:207,880,972...207,911,125
Ensembl chr 1:207,880,972...207,911,402
G
CD74
CD74 molecule
increases expression
EXP
clothianidin results in increased expression of CD74 mRNA
CTD
PMID:31626844
NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
G
CD8B
CD8 subunit beta
increases expression
EXP
clothianidin results in increased expression of CD8B mRNA
CTD
PMID:31626844
NCBI chr 2:86,815,369...86,861,886
Ensembl chr 2:86,815,339...86,861,924
G
CDH8
cadherin 8
decreases expression
EXP
clothianidin results in decreased expression of CDH8 mRNA
CTD
PMID:31626844
NCBI chr16:61,647,250...62,036,438
Ensembl chr16:61,647,242...62,037,035
G
CDRT15L2
CMT1A duplicated region transcript 15 like 2
increases expression
EXP
clothianidin results in increased expression of CDRT15L2 mRNA
CTD
PMID:31626844
NCBI chr17:20,579,724...20,580,911
Ensembl chr17:20,579,724...20,580,911
G
CEACAM6
CEA cell adhesion molecule 6
increases expression
EXP
clothianidin results in increased expression of CEACAM6 mRNA
CTD
PMID:31626844
NCBI chr19:41,755,530...41,772,211
Ensembl chr19:41,750,977...41,772,211
G
CEMIP
cell migration inducing hyaluronidase 1
increases expression
EXP
clothianidin results in increased expression of CEMIP mRNA
CTD
PMID:31626844
NCBI chr15:80,779,370...80,951,771
Ensembl chr15:80,779,343...80,951,776
G
CES2
carboxylesterase 2
multiple interactions
EXP
[clothianidin co-treated with thiacloprid] results in increased expression of CES2 protein
CTD
PMID:32201337
NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096
G
CFAP107
cilia and flagella associated protein 107
decreases expression
EXP
clothianidin results in decreased expression of CFAP107 mRNA
CTD
PMID:31626844
NCBI chr 1:12,746,200...12,763,699
Ensembl chr 1:12,746,200...12,763,699
G
CHAT
choline O-acetyltransferase
decreases expression
ISO
clothianidin results in decreased expression of CHAT mRNA
CTD
PMID:35264496
NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942
G
CHRNA4
cholinergic receptor nicotinic alpha 4 subunit
multiple interactions
EXP
clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]
CTD
PMID:21538459
NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
decreases expression
ISO
clothianidin results in decreased expression of CHRNA7 mRNA
CTD
PMID:35264496
NCBI chr15:32,030,483...32,173,018
Ensembl chr15:31,923,438...32,173,018
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO EXP
clothianidin results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein]; clothianidin results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein] clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]
CTD
PMID:16981889 PMID:21538459 PMID:25459289
NCBI chr 1:154,567,778...154,580,013
Ensembl chr 1:154,567,778...154,580,013
G
CHST3
carbohydrate sulfotransferase 3
increases expression
EXP
clothianidin results in increased expression of CHST3 mRNA
CTD
PMID:29044138
NCBI chr10:71,964,395...72,013,558
Ensembl chr10:71,964,395...72,013,558
G
CLDN14
claudin 14
decreases expression
EXP
clothianidin results in decreased expression of CLDN14 mRNA
CTD
PMID:35690182
NCBI chr21:36,460,621...36,576,569
Ensembl chr21:36,460,621...36,576,569
G
CLEC3B
C-type lectin domain family 3 member B
increases expression
EXP
clothianidin results in increased expression of CLEC3B mRNA
CTD
PMID:31626844
NCBI chr 3:45,026,303...45,036,071
Ensembl chr 3:45,001,548...45,036,071
G
CMTM5
CKLF like MARVEL transmembrane domain containing 5
increases expression
EXP
clothianidin results in increased expression of CMTM5 mRNA
CTD
PMID:31626844
NCBI chr14:23,376,771...23,379,772
Ensembl chr14:23,376,773...23,379,772
G
CNTNAP1
contactin associated protein 1
decreases expression
EXP
clothianidin results in decreased expression of CNTNAP1 mRNA
CTD
PMID:31626844
NCBI chr17:42,682,531...42,699,993
Ensembl chr17:42,682,531...42,699,993
G
COL12A1
collagen type XII alpha 1 chain
decreases expression
EXP
clothianidin results in decreased expression of COL12A1 mRNA
CTD
PMID:31626844
NCBI chr 6:75,084,326...75,206,053
Ensembl chr 6:75,084,326...75,206,267
G
COL1A1
collagen type I alpha 1 chain
decreases expression
EXP
clothianidin results in decreased expression of COL1A1 mRNA
CTD
PMID:29044138
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL5A2
collagen type V alpha 2 chain
decreases expression
EXP
clothianidin results in decreased expression of COL5A2 mRNA
CTD
PMID:35690182
NCBI chr 2:189,031,898...189,441,111
Ensembl chr 2:189,031,898...189,225,312
G
COL6A2
collagen type VI alpha 2 chain
increases expression
EXP
clothianidin results in increased expression of COL6A2 mRNA
CTD
PMID:31626844
NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848
G
COL7A1
collagen type VII alpha 1 chain
decreases expression
EXP
clothianidin results in decreased expression of COL7A1 mRNA
CTD
PMID:29044138
NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,329
G
CORO2B
coronin 2B
decreases expression
EXP
clothianidin results in decreased expression of CORO2B mRNA
CTD
PMID:31626844
NCBI chr15:68,518,373...68,727,806
Ensembl chr15:68,578,993...68,727,806
G
CPEB3
cytoplasmic polyadenylation element binding protein 3
decreases expression
EXP
clothianidin results in decreased expression of CPEB3 mRNA
CTD
PMID:31626844
NCBI chr10:92,046,692...92,291,233
Ensembl chr10:92,046,692...92,291,078
G
CPNE4
copine 4
increases expression
EXP
clothianidin results in increased expression of CPNE4 mRNA
CTD
PMID:31626844
NCBI chr 3:131,533,569...132,039,606
Ensembl chr 3:131,533,555...132,285,410
G
CSMD1
CUB and Sushi multiple domains 1
increases expression
EXP
clothianidin results in increased expression of CSMD1 mRNA
CTD
PMID:31626844
NCBI chr 8:2,935,361...4,994,914
Ensembl chr 8:2,935,353...4,994,972
G
CXADR
CXADR Ig-like cell adhesion molecule
increases expression
EXP
clothianidin results in increased expression of CXADR mRNA
CTD
PMID:29044138
NCBI chr21:17,513,043...17,636,262
Ensembl chr21:17,513,043...17,593,579
G
CYBA
cytochrome b-245 alpha chain
decreases expression
EXP
clothianidin results in decreased expression of CYBA mRNA
CTD
PMID:35690182
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
increases expression multiple interactions
EXP
clothianidin results in increased expression of CYP1A2 mRNA [clothianidin co-treated with enilconazole] results in increased expression of CYP1A2 mRNA; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP1A2 mRNA
CTD
PMID:32201337
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
multiple interactions
EXP
[clothianidin co-treated with enilconazole] results in increased expression of CYP1B1 protein
CTD
PMID:32201337
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP2A6
cytochrome P450 family 2 subfamily A member 6
multiple interactions
EXP
[clothianidin co-treated with enilconazole] results in decreased expression of CYP2A6 protein; [clothianidin co-treated with thiacloprid] results in increased expression of CYP2A6 protein
CTD
PMID:32201337
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
multiple interactions
EXP
[clothianidin co-treated with thiacloprid] results in increased expression of CYP2B6 protein
CTD
PMID:32201337
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
multiple interactions
EXP
[clothianidin co-treated with thiacloprid] results in increased expression of CYP2C9 protein
CTD
PMID:32201337
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions decreases expression
EXP
[clothianidin co-treated with enilconazole] results in decreased expression of CYP2E1 mRNA; [clothianidin co-treated with thiacloprid] results in increased expression of CYP2E1 protein; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in decreased expression of CYP2E1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of CYP2E1 mRNA clothianidin results in decreased expression of CYP2E1 mRNA
CTD
PMID:32201337
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
multiple interactions increases expression
EXP
[clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 mRNA; [clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 protein; [clothianidin co-treated with thiacloprid] results in increased expression of CYP3A4 protein; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP3A4 mRNA clothianidin results in increased expression of CYP3A4 mRNA
CTD
PMID:32201337
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
increases expression multiple interactions
EXP
clothianidin results in increased expression of CYP3A5 mRNA [clothianidin co-treated with enilconazole] results in increased expression of CYP3A5 protein; [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A5 mRNA
CTD
PMID:32201337
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression multiple interactions
ISO
clothianidin results in decreased expression of CYP7A1 mRNA [enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA
CTD
PMID:33426623
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYTH4
cytohesin 4
increases expression
EXP
clothianidin results in increased expression of CYTH4 mRNA
CTD
PMID:31626844
NCBI chr22:37,282,508...37,315,341
Ensembl chr22:37,282,027...37,315,341
G
DACT1
dishevelled binding antagonist of beta catenin 1
decreases expression
EXP
clothianidin results in decreased expression of DACT1 mRNA
CTD
PMID:31626844
NCBI chr14:58,634,061...58,648,321
Ensembl chr14:58,633,967...58,648,321
G
DEFA5
defensin alpha 5
decreases expression
EXP
clothianidin results in decreased expression of DEFA5 mRNA
CTD
PMID:31626844
NCBI chr 8:7,055,304...7,056,739
Ensembl chr 8:7,055,304...7,056,739
G
DES
desmin
increases expression
EXP
clothianidin results in increased expression of DES mRNA
CTD
PMID:31626844
NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735
G
DGKD
diacylglycerol kinase delta
increases expression
EXP
clothianidin results in increased expression of DGKD mRNA
CTD
PMID:31626844
NCBI chr 2:233,354,494...233,472,098
Ensembl chr 2:233,354,494...233,472,104
G
DIO3
iodothyronine deiodinase 3
increases expression
EXP
clothianidin results in increased expression of DIO3 mRNA
CTD
PMID:31626844
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
G
DLL3
delta like canonical Notch ligand 3
decreases expression
EXP
clothianidin results in decreased expression of DLL3 mRNA
CTD
PMID:31626844
NCBI chr19:39,498,947...39,508,469
Ensembl chr19:39,498,895...39,508,481
G
DNAI7
dynein axonemal intermediate chain 7
decreases expression
EXP
clothianidin results in decreased expression of DNAI7 mRNA
CTD
PMID:31626844
NCBI chr12:25,107,047...25,195,160
Ensembl chr12:25,108,289...25,195,162
G
DNAJC21
DnaJ heat shock protein family (Hsp40) member C21
increases expression
EXP
clothianidin results in increased expression of DNAJC21 mRNA
CTD
PMID:31626844
NCBI chr 5:34,929,559...34,958,964
Ensembl chr 5:34,929,559...34,958,964
G
DNAJC28
DnaJ heat shock protein family (Hsp40) member C28
decreases expression
EXP
clothianidin results in decreased expression of DNAJC28 mRNA
CTD
PMID:31626844
NCBI chr21:33,488,055...33,491,716
Ensembl chr21:33,488,055...33,491,716
G
DNAJC5G
DnaJ heat shock protein family (Hsp40) member C5 gamma
increases expression
EXP
clothianidin results in increased expression of DNAJC5G mRNA
CTD
PMID:31626844
NCBI chr 2:27,275,433...27,281,499
Ensembl chr 2:27,275,433...27,281,499
G
DNASE1L2
deoxyribonuclease 1 like 2
decreases expression
EXP
clothianidin results in decreased expression of DNASE1L2 mRNA
CTD
PMID:29044138
NCBI chr16:2,236,444...2,238,711
Ensembl chr16:2,235,816...2,238,711
G
DNHD1
dynein heavy chain domain 1
decreases expression
EXP
clothianidin results in decreased expression of DNHD1 mRNA
CTD
PMID:29044138
NCBI chr11:6,497,280...6,572,020
Ensembl chr11:6,497,260...6,593,758
G
DOK5
docking protein 5
decreases expression
EXP
clothianidin results in decreased expression of DOK5 mRNA
CTD
PMID:31626844
NCBI chr20:54,475,593...54,651,169
Ensembl chr20:54,475,593...54,651,169
G
DUS3L
dihydrouridine synthase 3 like
increases expression
EXP
clothianidin results in increased expression of DUS3L mRNA
CTD
PMID:31626844
NCBI chr19:5,785,140...5,791,163
Ensembl chr19:5,784,832...5,791,225
G
DUSP15
dual specificity phosphatase 15
increases expression
EXP
clothianidin results in increased expression of DUSP15 mRNA
CTD
PMID:29044138
NCBI chr20:31,845,593...31,870,664
Ensembl chr20:31,847,637...31,870,664
G
DUSP16
dual specificity phosphatase 16
decreases expression
EXP
clothianidin results in decreased expression of DUSP16 mRNA
CTD
PMID:31626844
NCBI chr12:12,473,282...12,562,863
Ensembl chr12:12,473,282...12,562,863
G
EAF2
ELL associated factor 2
decreases expression
EXP
clothianidin results in decreased expression of EAF2 mRNA
CTD
PMID:31626844
NCBI chr 3:121,835,209...121,886,526
Ensembl chr 3:121,835,183...121,886,526
G
ECE2
endothelin converting enzyme 2
increases expression
EXP
clothianidin results in increased expression of ECE2 mRNA
CTD
PMID:31626844
NCBI chr 3:184,276,022...184,293,031
Ensembl chr 3:184,276,011...184,293,031
G
EFCAB12
EF-hand calcium binding domain 12
decreases expression
EXP
clothianidin results in decreased expression of EFCAB12 mRNA
CTD
PMID:29044138
NCBI chr 3:129,401,321...129,428,636
Ensembl chr 3:129,401,321...129,428,636
G
EFS
embryonal Fyn-associated substrate
decreases expression
EXP
clothianidin results in decreased expression of EFS mRNA
CTD
PMID:31626844
NCBI chr14:23,356,406...23,365,172
Ensembl chr14:23,356,403...23,365,752
G
EIF3F
eukaryotic translation initiation factor 3 subunit F
decreases expression
EXP
clothianidin results in decreased expression of EIF3F mRNA
CTD
PMID:31626844
NCBI chr11:7,987,337...8,001,852
Ensembl chr11:7,970,251...8,001,862
G
ELF1
E74 like ETS transcription factor 1
increases expression
EXP
clothianidin results in increased expression of ELF1 mRNA
CTD
PMID:31626844
NCBI chr13:40,931,919...41,061,386
Ensembl chr13:40,931,924...41,061,440
G
ELMOD1
ELMO domain containing 1
decreases expression
EXP
clothianidin results in decreased expression of ELMOD1 mRNA
CTD
PMID:31626844
NCBI chr11:107,591,147...107,666,779
Ensembl chr11:107,591,091...107,666,779
G
ELN
elastin
decreases expression multiple interactions
ISO
clothianidin results in decreased expression of ELN mRNA [enilconazole co-treated with clothianidin] results in decreased expression of ELN mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of ELN mRNA
CTD
PMID:33426623
NCBI chr 7:74,028,173...74,069,907
Ensembl chr 7:74,027,789...74,069,907
G
ENOX1
ecto-NOX disulfide-thiol exchanger 1
increases expression
EXP
clothianidin results in increased expression of ENOX1 mRNA
CTD
PMID:35690182
NCBI chr13:43,213,130...43,786,972
Ensembl chr13:43,213,130...43,786,972
G
ENPP4
ectonucleotide pyrophosphatase/phosphodiesterase 4
increases expression
EXP
clothianidin results in increased expression of ENPP4 mRNA
CTD
PMID:29044138
NCBI chr 6:46,129,989...46,146,688
Ensembl chr 6:46,129,989...46,146,688
G
EPDR1
ependymin related 1
increases expression
EXP
clothianidin results in increased expression of EPDR1 mRNA
CTD
PMID:29044138
NCBI chr 7:37,920,640...37,951,936
Ensembl chr 7:37,920,640...37,951,936
G
EPN3
epsin 3
decreases expression
EXP
clothianidin results in decreased expression of EPN3 mRNA
CTD
PMID:31626844
NCBI chr17:50,532,735...50,543,750
Ensembl chr17:50,532,682...50,543,750
G
EPS8
EGFR pathway substrate 8, signaling adaptor
increases expression
EXP
clothianidin results in increased expression of EPS8 mRNA
CTD
PMID:29044138
NCBI chr12:15,620,134...15,789,388
Ensembl chr12:15,620,134...15,882,329
G
ERBB3
erb-b2 receptor tyrosine kinase 3
increases expression
EXP
clothianidin results in increased expression of ERBB3 mRNA
CTD
PMID:31626844
NCBI chr12:56,080,108...56,103,505
Ensembl chr12:56,076,799...56,103,505
G
ERGIC1
endoplasmic reticulum-golgi intermediate compartment 1
increases expression
EXP
clothianidin results in increased expression of ERGIC1 mRNA
CTD
PMID:31626844
NCBI chr 5:172,834,251...172,952,683
Ensembl chr 5:172,834,251...172,952,792
G
EXOC4
exocyst complex component 4
decreases expression
EXP
clothianidin results in decreased expression of EXOC4 mRNA
CTD
PMID:31626844
NCBI chr 7:133,253,078...134,100,951
Ensembl chr 7:133,253,073...134,066,589
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
EXP
clothianidin results in decreased expression of EZH2 mRNA
CTD
PMID:31626844
NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
G
F2
coagulation factor II, thrombin
decreases expression
EXP
clothianidin results in decreased expression of F2 mRNA
CTD
PMID:31626844
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
FAM110C
family with sequence similarity 110 member C
increases expression
EXP
clothianidin results in increased expression of FAM110C mRNA
CTD
PMID:31626844
NCBI chr 2:38,814...46,505
Ensembl chr 2:38,814...46,870
G
FAM131A
family with sequence similarity 131 member A
decreases expression
EXP
clothianidin results in decreased expression of FAM131A mRNA
CTD
PMID:31626844
NCBI chr 3:184,335,926...184,346,275
Ensembl chr 3:184,335,926...184,348,421
G
FAM151B
family with sequence similarity 151 member B
decreases expression
EXP
clothianidin results in decreased expression of FAM151B mRNA
CTD
PMID:31626844
NCBI chr 5:80,488,100...80,542,563
Ensembl chr 5:80,487,969...80,542,563
G
FAM162B
family with sequence similarity 162 member B
increases expression
EXP
clothianidin results in increased expression of FAM162B mRNA
CTD
PMID:31626844
NCBI chr 6:116,752,197...116,765,719
Ensembl chr 6:116,752,197...116,765,719
G
FAM169A
family with sequence similarity 169 member A
increases expression
EXP
clothianidin results in increased expression of FAM169A mRNA
CTD
PMID:29044138
NCBI chr 5:74,777,574...74,866,966
Ensembl chr 5:74,777,574...74,866,966
G
FAM229A
family with sequence similarity 229 member A
decreases expression
EXP
clothianidin results in decreased expression of FAM229A mRNA
CTD
PMID:29044138
NCBI chr 1:32,361,270...32,362,485
Ensembl chr 1:32,361,270...32,364,278
G
FAM47B
family with sequence similarity 47 member B
increases expression
EXP
clothianidin results in increased expression of FAM47B mRNA
CTD
PMID:31626844
NCBI chr X:34,942,796...34,944,915
Ensembl chr X:34,942,796...34,944,915
G
FAR2P1
fatty acyl-CoA reductase 2 pseudogene 1
decreases expression
EXP
clothianidin results in decreased expression of FAR2P1 mRNA
CTD
PMID:31626844
NCBI chr 2:130,025,998...130,051,131
Ensembl chr 2:130,028,309...130,040,560
G
FASLG
Fas ligand
increases expression
ISO
clothianidin results in increased expression of FASLG mRNA
CTD
PMID:35264496
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FBXL19-AS1
FBXL19 antisense RNA 1
decreases expression
EXP
clothianidin results in decreased expression of FBXL19-AS1 mRNA
CTD
PMID:29044138
NCBI chr16:30,919,319...30,923,269
Ensembl chr16:30,919,319...30,923,269
G
FBXO33
F-box protein 33
decreases expression
EXP
clothianidin results in decreased expression of FBXO33 mRNA
CTD
PMID:31626844
NCBI chr14:39,397,684...39,432,433
Ensembl chr14:39,397,684...39,432,466
G
FBXW10B
F-box and WD repeat domain containing 10B
increases expression
EXP
clothianidin results in increased expression of FBXW10B mRNA
CTD
PMID:31626844
NCBI chr17:15,565,482...15,619,704
Ensembl chr17:15,565,483...15,619,704
G
FCN3
ficolin 3
increases expression
EXP
clothianidin results in increased expression of FCN3 mRNA
CTD
PMID:31626844
NCBI chr 1:27,369,110...27,374,824
Ensembl chr 1:27,369,110...27,374,824
G
FER1L4
fer-1 like family member 4 (pseudogene)
decreases expression
EXP
clothianidin results in decreased expression of FER1L4 mRNA
CTD
PMID:29044138
NCBI chr20:35,558,737...35,607,562
Ensembl chr20:35,558,866...35,607,494
G
FGFR1
fibroblast growth factor receptor 1
increases expression
ISO
clothianidin results in increased expression of FGFR1 mRNA
CTD
PMID:36858607
NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
G
FHIT
fragile histidine triad diadenosine triphosphatase
increases expression
EXP
clothianidin results in increased expression of FHIT mRNA
CTD
PMID:35690182
NCBI chr 3:59,747,277...61,251,452
Ensembl chr 3:59,747,277...61,251,459
G
FILIP1
filamin A interacting protein 1
increases expression
EXP
clothianidin results in increased expression of FILIP1 mRNA
CTD
PMID:31626844
NCBI chr 6:75,291,859...75,493,800
Ensembl chr 6:75,291,859...75,493,800
G
FITM1
fat storage inducing transmembrane protein 1
increases expression
EXP
clothianidin results in increased expression of FITM1 mRNA
CTD
PMID:31626844
NCBI chr14:24,130,659...24,132,847
Ensembl chr14:24,130,659...24,132,849
G
FOLR2
folate receptor beta
increases expression
EXP
clothianidin results in increased expression of FOLR2 mRNA
CTD
PMID:31626844
NCBI chr11:72,216,794...72,221,950
Ensembl chr11:72,216,601...72,221,950
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
increases expression
EXP
clothianidin results in increased expression of FOSL1 mRNA
CTD
PMID:35690182
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FOXO1
forkhead box O1
increases expression
EXP
clothianidin results in increased expression of FOXO1 mRNA
CTD
PMID:31626844
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
G
FOXO4
forkhead box O4
decreases expression
EXP
clothianidin results in decreased expression of FOXO4 mRNA
CTD
PMID:29044138
NCBI chr X:71,095,851...71,103,532
Ensembl chr X:71,095,851...71,103,532
G
FTCDNL1
formiminotransferase cyclodeaminase N-terminal like
increases expression
EXP
clothianidin results in increased expression of FTCDNL1 mRNA
CTD
PMID:29044138
NCBI chr 2:199,663,835...199,851,192
Ensembl chr 2:199,760,544...199,851,192
G
FYB1
FYN binding protein 1
decreases expression
EXP
clothianidin results in decreased expression of FYB1 mRNA
CTD
PMID:31626844
NCBI chr 5:39,105,252...39,274,528
Ensembl chr 5:39,105,252...39,274,528
G
GABRG1
gamma-aminobutyric acid type A receptor subunit gamma1
increases expression
ISO
clothianidin results in increased expression of GABRG1 mRNA
CTD
PMID:35264496
NCBI chr 4:46,035,769...46,124,054
Ensembl chr 4:46,035,769...46,124,054
G
GABRP
gamma-aminobutyric acid type A receptor subunit pi
decreases expression
ISO
clothianidin results in decreased expression of GABRP mRNA
CTD
PMID:35264496
NCBI chr 5:170,782,720...170,814,047
Ensembl chr 5:170,763,350...170,814,047
G
GAGE10
G antigen 10
increases expression
EXP
clothianidin results in increased expression of GAGE10 mRNA
CTD
PMID:31626844
NCBI chr X:49,303,646...49,319,844
Ensembl chr X:49,303,646...49,319,841
G
GASK1A
golgi associated kinase 1A
increases expression
EXP
clothianidin results in increased expression of FAM198A mRNA
CTD
PMID:31626844
NCBI chr 3:42,979,311...43,057,715
Ensembl chr 3:42,979,087...43,067,898
G
GDF15
growth differentiation factor 15
increases expression
EXP
clothianidin results in increased expression of GDF15 mRNA
CTD
PMID:35690182
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GHRHR
growth hormone releasing hormone receptor
increases expression
EXP
clothianidin results in increased expression of GHRHR mRNA
CTD
PMID:31626844
NCBI chr 7:30,963,953...30,979,528
Ensembl chr 7:30,938,669...30,993,254
G
GLI1
GLI family zinc finger 1
decreases expression
EXP
clothianidin results in decreased expression of GLI1 mRNA
CTD
PMID:31626844
NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
G
GNGT1
G protein subunit gamma transducin 1
decreases expression
EXP
clothianidin results in decreased expression of GNGT1 mRNA
CTD
PMID:31626844
NCBI chr 7:93,906,567...93,911,265
Ensembl chr 7:93,591,573...93,911,265
G
GNMT
glycine N-methyltransferase
decreases expression
EXP
clothianidin results in decreased expression of GNMT mRNA
CTD
PMID:35690182
NCBI chr 6:42,960,754...42,963,880
Ensembl chr 6:42,960,754...42,963,880
G
GPC6
glypican 6
increases expression
EXP
clothianidin results in increased expression of GPC6 mRNA
CTD
PMID:31626844
NCBI chr13:93,216,529...94,408,020
Ensembl chr13:93,226,807...94,408,020
G
GPCPD1
glycerophosphocholine phosphodiesterase 1
increases expression
EXP
clothianidin results in increased expression of GPCPD1 mRNA
CTD
PMID:31626844
NCBI chr20:5,544,439...5,611,006
Ensembl chr20:5,544,439...5,611,006
G
GPIHBP1
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
increases expression
EXP
clothianidin results in increased expression of GPIHBP1 mRNA
CTD
PMID:31626844
NCBI chr 8:143,213,218...143,217,170
Ensembl chr 8:143,213,218...143,217,170
G
GPR15LG
G protein-coupled receptor 15 ligand
decreases expression
EXP
clothianidin results in decreased expression of GPR15LG mRNA
CTD
PMID:31626844
NCBI chr10:84,173,801...84,185,294
Ensembl chr10:84,173,801...84,185,294
G
GPX4
glutathione peroxidase 4
decreases expression
ISO
clothianidin results in decreased expression of GPX4 protein
CTD
PMID:25960033
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
GRAMD1C
GRAM domain containing 1C
decreases expression
EXP
clothianidin results in decreased expression of GRAMD1C mRNA
CTD
PMID:31626844
NCBI chr 3:113,828,192...113,947,174
Ensembl chr 3:113,828,182...113,947,174
G
GRAMD2A
GRAM domain containing 2A
decreases expression
EXP
clothianidin results in decreased expression of GRAMD2A mRNA
CTD
PMID:31626844
NCBI chr15:72,159,806...72,197,787
Ensembl chr15:72,159,806...72,197,787
G
GSKIP
GSK3B interacting protein
increases expression
EXP
clothianidin results in increased expression of GSKIP mRNA
CTD
PMID:29044138
NCBI chr14:96,363,526...96,387,290
Ensembl chr14:96,363,452...96,387,288
G
GTF3C5
general transcription factor IIIC subunit 5
increases expression
EXP
clothianidin results in increased expression of GTF3C5 mRNA
CTD
PMID:31626844
NCBI chr 9:133,030,708...133,058,503
Ensembl chr 9:133,030,675...133,058,503
G
GTSF1L
gametocyte specific factor 1 like
increases expression
EXP
clothianidin results in increased expression of GTSF1L mRNA
CTD
PMID:31626844
NCBI chr20:43,726,164...43,727,002
Ensembl chr20:43,726,164...43,727,002
G
GYPC
glycophorin C (Gerbich blood group)
increases expression
EXP
clothianidin results in increased expression of GYPC mRNA
CTD
PMID:31626844
NCBI chr 2:126,656,158...126,696,667
Ensembl chr 2:126,656,133...126,696,667
G
H1-7
H1.7 linker histone
increases expression
EXP
clothianidin results in increased expression of H1-7 mRNA
CTD
PMID:31626844
NCBI chr12:48,328,980...48,330,279
Ensembl chr12:48,328,980...48,330,279
G
HACD2
3-hydroxyacyl-CoA dehydratase 2
increases expression
EXP
clothianidin results in increased expression of HACD2 mRNA
CTD
PMID:29044138
NCBI chr 3:123,491,554...123,585,053
Ensembl chr 3:123,490,820...123,585,053
G
HCK
HCK proto-oncogene, Src family tyrosine kinase
increases expression
EXP
clothianidin results in increased expression of HCK mRNA
CTD
PMID:31626844
NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
G
HECTD2
HECT domain E3 ubiquitin protein ligase 2
increases expression
EXP
clothianidin results in increased expression of HECTD2 mRNA
CTD
PMID:29044138
NCBI chr10:91,409,235...91,514,820
Ensembl chr10:91,409,280...91,514,829
G
HECW2
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
decreases expression
EXP
clothianidin results in decreased expression of HECW2 mRNA
CTD
PMID:31626844
NCBI chr 2:196,194,072...196,593,554
Ensembl chr 2:196,189,099...196,593,684
G
HGF
hepatocyte growth factor
decreases expression
EXP
clothianidin results in decreased expression of HGF mRNA
CTD
PMID:31626844
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
HID1
HID1 domain containing
decreases expression
EXP
clothianidin results in decreased expression of HID1 mRNA
CTD
PMID:31626844
NCBI chr17:74,950,742...74,972,759
Ensembl chr17:74,950,742...74,973,166
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
increases expression
EXP
clothianidin results in increased expression of HLA-DQB1 mRNA
CTD
PMID:31626844
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HMBS
hydroxymethylbilane synthase
increases expression
EXP
clothianidin results in increased expression of HMBS mRNA
CTD
PMID:31626844
NCBI chr11:119,084,881...119,093,549
Ensembl chr11:119,084,866...119,093,834
G
HNF1B
HNF1 homeobox B
increases expression
EXP
clothianidin results in increased expression of HNF1B mRNA
CTD
PMID:31626844
NCBI chr17:37,686,431...37,745,059
Ensembl chr17:37,686,431...37,745,059
G
HNF4A
hepatocyte nuclear factor 4 alpha
increases expression
EXP
clothianidin results in increased expression of HNF4A mRNA
CTD
PMID:31626844
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
G
HNRNPK
heterogeneous nuclear ribonucleoprotein K
decreases expression
EXP
clothianidin results in decreased expression of HNRNPK mRNA
CTD
PMID:31626844
NCBI chr 9:83,968,083...83,980,615
Ensembl chr 9:83,968,083...83,980,631
G
IFT70B
intraflagellar transport 70B
decreases expression
EXP
clothianidin results in decreased expression of IFT70B mRNA
CTD
PMID:31626844
NCBI chr 2:177,548,998...177,552,796
Ensembl chr 2:177,548,998...177,552,796
G
IL17RE
interleukin 17 receptor E
decreases expression
EXP
clothianidin results in decreased expression of IL17RE mRNA
CTD
PMID:29044138
NCBI chr 3:9,902,093...9,916,402
Ensembl chr 3:9,902,612...9,916,402
G
IL18BP
interleukin 18 binding protein
decreases expression
EXP
clothianidin results in decreased expression of IL18BP mRNA
CTD
PMID:29044138
NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315
G
IL2RG
interleukin 2 receptor subunit gamma
increases expression
EXP
clothianidin results in increased expression of IL2RG mRNA
CTD
PMID:31626844
NCBI chr X:71,107,404...71,111,577
Ensembl chr X:71,107,404...71,112,108
G
IMMP1L
inner mitochondrial membrane peptidase subunit 1
increases expression
EXP
clothianidin results in increased expression of IMMP1L mRNA
CTD
PMID:31626844
NCBI chr11:31,432,401...31,509,622
Ensembl chr11:31,432,401...31,509,645
G
INSYN2B
inhibitory synaptic factor family member 2B
decreases expression
EXP
clothianidin results in decreased expression of INSYN2B mRNA
CTD
PMID:31626844
NCBI chr 5:169,861,303...169,980,495
Ensembl chr 5:169,861,303...169,980,495
G
IRX5
iroquois homeobox 5
decreases expression
EXP
clothianidin results in decreased expression of IRX5 mRNA
CTD
PMID:31626844
NCBI chr16:54,930,865...54,934,485
Ensembl chr16:54,930,865...54,934,485
G
ITSN1
intersectin 1
decreases expression
EXP
clothianidin results in decreased expression of ITSN1 mRNA
CTD
PMID:31626844
NCBI chr21:33,642,501...33,899,861
Ensembl chr21:33,642,400...33,899,861
G
JAK2
Janus kinase 2
decreases expression
EXP
clothianidin results in decreased expression of JAK2 mRNA
CTD
PMID:31626844
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
KAT6B
lysine acetyltransferase 6B
decreases expression
EXP
clothianidin results in decreased expression of KAT6B mRNA
CTD
PMID:31626844
NCBI chr10:74,824,936...75,032,624
Ensembl chr10:74,824,927...75,032,624
G
KCNC4
potassium voltage-gated channel subfamily C member 4
increases expression
EXP
clothianidin results in increased expression of KCNC4 mRNA
CTD
PMID:31626844
NCBI chr 1:110,210,314...110,284,080
Ensembl chr 1:110,210,314...110,283,100
G
KCND3
potassium voltage-gated channel subfamily D member 3
decreases expression
EXP
clothianidin results in decreased expression of KCND3 mRNA
CTD
PMID:31626844
NCBI chr 1:111,770,662...111,989,668
Ensembl chr 1:111,770,662...111,989,668
G
KCNK1
potassium two pore domain channel subfamily K member 1
decreases expression
EXP
clothianidin results in decreased expression of KCNK1 mRNA
CTD
PMID:31626844
NCBI chr 1:233,614,106...233,672,514
Ensembl chr 1:233,614,106...233,672,514
G
KCNMA1
potassium calcium-activated channel subfamily M alpha 1
decreases expression
EXP
clothianidin results in decreased expression of KCNMA1 mRNA
CTD
PMID:31626844 PMID:35690182
NCBI chr10:76,869,602...77,637,808
Ensembl chr10:76,869,601...77,638,369
G
KIF7
kinesin family member 7
increases expression
EXP
clothianidin results in increased expression of KIF7 mRNA
CTD
PMID:31626844
NCBI chr15:89,617,309...89,663,049
Ensembl chr15:89,608,789...89,663,086
G
KIFC3
kinesin family member C3
increases expression
EXP
clothianidin results in increased expression of KIFC3 mRNA
CTD
PMID:31626844
NCBI chr16:57,758,217...57,862,858
Ensembl chr16:57,758,217...57,863,053
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
increases expression
EXP
clothianidin results in increased expression of KIT mRNA
CTD
PMID:31626844
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
G
KLHDC9
kelch domain containing 9
decreases expression
EXP
clothianidin results in decreased expression of KLHDC9 mRNA
CTD
PMID:31626844
NCBI chr 1:161,098,361...161,100,346
Ensembl chr 1:161,098,361...161,100,346
G
KPNA6
karyopherin subunit alpha 6
increases expression
EXP
clothianidin results in increased expression of KPNA6 mRNA
CTD
PMID:31626844
NCBI chr 1:32,108,056...32,176,563
Ensembl chr 1:32,108,056...32,176,563
G
KRT28
keratin 28
increases expression
EXP
clothianidin results in increased expression of KRT28 mRNA
CTD
PMID:31626844
NCBI chr17:40,792,196...40,799,959
Ensembl chr17:40,792,196...40,799,959
G
KRTAP19-5
keratin associated protein 19-5
increases expression
EXP
clothianidin results in increased expression of KRTAP19-5 mRNA
CTD
PMID:31626844
NCBI chr21:30,501,657...30,502,141
Ensembl chr21:30,501,657...30,502,141
G
KRTAP9-8
keratin associated protein 9-8
increases expression
EXP
clothianidin results in increased expression of KRTAP9-8 mRNA
CTD
PMID:31626844
NCBI chr17:41,237,999...41,239,004
Ensembl chr17:41,237,999...41,239,004
G
KSR1
kinase suppressor of ras 1
decreases expression
EXP
clothianidin results in decreased expression of KSR1 mRNA
CTD
PMID:31626844
NCBI chr17:27,456,448...27,626,435
Ensembl chr17:27,456,448...27,626,438
G
KY
kyphoscoliosis peptidase
multiple interactions decreases expression
ISO
[enilconazole co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of KY mRNA clothianidin results in decreased expression of KY mRNA
CTD
PMID:33426623
NCBI chr 3:134,599,923...134,651,022
Ensembl chr 3:134,599,923...134,651,636
G
L3MBTL1
L3MBTL histone methyl-lysine binding protein 1
decreases expression
EXP
clothianidin results in decreased expression of L3MBTL1 mRNA
CTD
PMID:31626844
NCBI chr20:43,507,697...43,550,954
Ensembl chr20:43,489,442...43,550,954
G
LCNL1
lipocalin like 1
decreases expression
EXP
clothianidin results in decreased expression of LCNL1 mRNA
CTD
PMID:29044138
NCBI chr 9:136,982,993...136,985,758
Ensembl chr 9:136,981,904...136,986,410
G
LGALS12
galectin 12
increases expression
EXP
clothianidin results in increased expression of LGALS12 mRNA
CTD
PMID:31626844
NCBI chr11:63,506,084...63,516,772
Ensembl chr11:63,506,052...63,516,774
G
LGI4
leucine rich repeat LGI family member 4
increases expression
EXP
clothianidin results in increased expression of LGI4 mRNA
CTD
PMID:31626844
NCBI chr19:35,124,513...35,135,059
Ensembl chr19:35,124,513...35,142,451
G
LIF
LIF interleukin 6 family cytokine
decreases expression
EXP
clothianidin results in decreased expression of LIF mRNA
CTD
PMID:35690182
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
G
LIM2
lens intrinsic membrane protein 2
increases expression
EXP
clothianidin results in increased expression of LIM2 mRNA
CTD
PMID:31626844
NCBI chr19:51,379,909...51,387,974
Ensembl chr19:51,379,909...51,387,974
G
LINC00272
long intergenic non-protein coding RNA 272
increases expression
EXP
clothianidin results in increased expression of LINC00272 mRNA
CTD
PMID:31626844
NCBI chr 1:182,407,621...182,414,813
Ensembl chr 1:182,407,621...182,414,815
G
LINC00649
long intergenic non-protein coding RNA 649
decreases expression
EXP
clothianidin results in decreased expression of LINC00649 mRNA
CTD
PMID:31626844
NCBI chr21:33,931,122...33,971,186
Ensembl chr21:33,915,534...33,977,703
G
LINC01465
long intergenic non-protein coding RNA 1465
increases expression
EXP
clothianidin results in increased expression of LINC01465 mRNA
CTD
PMID:31626844
NCBI chr12:62,601,751...62,603,434
Ensembl chr12:62,601,751...62,603,690
G
LONRF1
LON peptidase N-terminal domain and ring finger 1
increases expression
EXP
clothianidin results in increased expression of LONRF1 mRNA
CTD
PMID:31626844
NCBI chr 8:12,721,906...12,755,526
Ensembl chr 8:12,721,906...12,756,073
G
LOX
lysyl oxidase
increases expression
EXP
clothianidin results in increased expression of LOX mRNA
CTD
PMID:29044138
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LPAR1
lysophosphatidic acid receptor 1
decreases expression
EXP
clothianidin results in decreased expression of LPAR1 mRNA
CTD
PMID:31626844
NCBI chr 9:110,873,263...111,038,998
Ensembl chr 9:110,873,263...111,038,470
G
LRIG1
leucine rich repeats and immunoglobulin like domains 1
increases expression
EXP
clothianidin results in increased expression of LRIG1 mRNA
CTD
PMID:31626844
NCBI chr 3:66,378,797...66,501,121
Ensembl chr 3:66,378,797...66,501,263
G
LRMDA
leucine rich melanocyte differentiation associated
decreases expression
EXP
clothianidin results in decreased expression of LRMDA mRNA
CTD
PMID:35690182
NCBI chr10:75,431,624...76,560,168
Ensembl chr10:75,431,624...76,560,168
G
LRRC74B
leucine rich repeat containing 74B
decreases expression
EXP
clothianidin results in decreased expression of LRRC74B mRNA
CTD
PMID:31626844
NCBI chr22:21,045,946...21,064,168
Ensembl chr22:21,045,946...21,064,168
G
LUZP2
leucine zipper protein 2
increases expression
EXP
clothianidin results in increased expression of LUZP2 mRNA
CTD
PMID:31626844
NCBI chr11:24,497,053...25,082,638
Ensembl chr11:24,496,970...25,082,638
G
LYSMD2
LysM domain containing 2
decreases expression
EXP
clothianidin results in decreased expression of LYSMD2 mRNA
CTD
PMID:31626844
NCBI chr15:51,723,011...51,751,451
Ensembl chr15:51,723,011...51,751,585
G
MAP1LC3C
microtubule associated protein 1 light chain 3 gamma
increases expression
EXP
clothianidin results in increased expression of MAP1LC3C mRNA
CTD
PMID:31626844
NCBI chr 1:241,995,490...242,001,393
Ensembl chr 1:241,995,490...241,999,098
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation
EXP
clothianidin results in increased phosphorylation of MAPK1 protein
CTD
PMID:31626844
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
increases phosphorylation
EXP
clothianidin results in increased phosphorylation of MAPK3 protein
CTD
PMID:31626844
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MCHR1
melanin concentrating hormone receptor 1
increases expression
EXP
clothianidin results in increased expression of MCHR1 mRNA
CTD
PMID:31626844
NCBI chr22:40,679,484...40,682,812
Ensembl chr22:40,679,273...40,682,812
G
MEGF11
multiple EGF like domains 11
multiple interactions decreases expression
ISO
[enilconazole co-treated with clothianidin] results in decreased expression of MEGF11 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of MEGF11 mRNA clothianidin results in decreased expression of MEGF11 mRNA
CTD
PMID:33426623
NCBI chr15:65,895,299...66,253,750
Ensembl chr15:65,895,079...66,253,756
G
MEIOC
meiosis specific with coiled-coil domain
increases expression
EXP
clothianidin results in increased expression of MEIOC mRNA
CTD
PMID:31626844
NCBI chr17:44,656,468...44,677,087
Ensembl chr17:44,656,404...44,690,308
G
METTL16
methyltransferase 16, RNA N6-adenosine
increases expression
EXP
clothianidin results in increased expression of METTL16 mRNA
CTD
PMID:31626844
NCBI chr17:2,415,715...2,511,888
Ensembl chr17:2,405,562...2,511,891
G
MICAL1
microtubule associated monooxygenase, calponin and LIM domain containing 1
increases expression
EXP
clothianidin results in increased expression of MICAL1 mRNA
CTD
PMID:31626844
NCBI chr 6:109,444,062...109,465,968
Ensembl chr 6:109,444,062...109,465,968
G
MICALL2
MICAL like 2
decreases expression
EXP
clothianidin results in decreased expression of MICALL2 mRNA
CTD
PMID:29044138
NCBI chr 7:1,434,359...1,459,470
Ensembl chr 7:1,428,465...1,459,470
G
MLANA
melan-A
increases expression
EXP
clothianidin results in increased expression of MLANA mRNA
CTD
PMID:31626844
NCBI chr 9:5,890,889...5,910,606
Ensembl chr 9:5,890,889...5,910,606
G
MME
membrane metalloendopeptidase
multiple interactions increases expression
ISO
[enilconazole co-treated with clothianidin] results in increased expression of MME mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of MME mRNA clothianidin results in increased expression of MME mRNA
CTD
PMID:33426623
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
G
MMP10
matrix metallopeptidase 10
increases expression
EXP
clothianidin results in increased expression of MMP10 mRNA
CTD
PMID:31626844
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
G
MS4A2
membrane spanning 4-domains A2
decreases expression
EXP
clothianidin results in decreased expression of MS4A2 mRNA
CTD
PMID:29044138
NCBI chr11:60,088,259...60,098,467
Ensembl chr11:60,088,261...60,098,467
G
MSS51
MSS51 mitochondrial translational activator
decreases expression
EXP
clothianidin results in decreased expression of MSS51 mRNA
CTD
PMID:29044138
NCBI chr10:73,423,579...73,433,561
Ensembl chr10:73,423,579...73,433,561
G
MTG1
mitochondrial ribosome associated GTPase 1
decreases expression
EXP
clothianidin results in decreased expression of MTG1 mRNA
CTD
PMID:29044138
NCBI chr10:133,394,157...133,422,520
Ensembl chr10:133,394,094...133,422,520
G
MUC22
mucin 22
increases expression
EXP
clothianidin results in increased expression of MUC22 mRNA
CTD
PMID:31626844
NCBI chr 6:31,005,952...31,035,402
Ensembl chr 6:31,010,474...31,035,402
G
MYL11
myosin light chain 11
decreases expression
EXP
clothianidin results in decreased expression of MYL11 mRNA
CTD
PMID:31626844
NCBI chr16:30,370,934...30,377,991
Ensembl chr16:30,370,934...30,377,991
G
MYL4
myosin light chain 4
decreases expression
EXP
clothianidin results in decreased expression of MYL4 mRNA
CTD
PMID:31626844
NCBI chr17:47,189,433...47,227,650
Ensembl chr17:47,200,446...47,223,679
G
MYL6
myosin light chain 6
decreases expression
EXP
clothianidin results in decreased expression of MYL6 mRNA
CTD
PMID:31626844
NCBI chr12:56,158,359...56,161,579
Ensembl chr12:56,158,346...56,163,496
G
MYO3B
myosin IIIB
increases expression
EXP
clothianidin results in increased expression of MYO3B mRNA
CTD
PMID:31626844
NCBI chr 2:170,178,147...170,655,167
Ensembl chr 2:170,178,145...170,655,171
G
MYORG
myogenesis regulating glycosidase (putative)
increases expression
EXP
clothianidin results in increased expression of MYORG mRNA
CTD
PMID:29044138
NCBI chr 9:34,366,666...34,376,898
Ensembl chr 9:34,366,666...34,376,898
G
MYT1L
myelin transcription factor 1 like
increases expression
EXP
clothianidin results in increased expression of MYT1L mRNA
CTD
PMID:31626844
NCBI chr 2:1,789,113...2,331,275
Ensembl chr 2:1,789,113...2,331,664
G
N4BP2L1
NEDD4 binding protein 2 like 1
increases expression
EXP
clothianidin results in increased expression of N4BP2L1 mRNA
CTD
PMID:31626844
NCBI chr13:32,400,723...32,429,615
Ensembl chr13:32,400,723...32,428,311
G
NADSYN1
NAD synthetase 1
decreases expression
EXP
clothianidin results in decreased expression of NADSYN1 mRNA
CTD
PMID:31626844
NCBI chr11:71,453,203...71,501,816
Ensembl chr11:71,453,109...71,524,107
G
NASP
nuclear autoantigenic sperm protein
decreases expression
EXP
clothianidin results in decreased expression of NASP mRNA
CTD
PMID:31626844
NCBI chr 1:45,584,041...45,618,893
Ensembl chr 1:45,583,846...45,618,904
G
NCF2
neutrophil cytosolic factor 2
increases expression
EXP
clothianidin results in increased expression of NCF2 mRNA
CTD
PMID:35690182
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
G
NDUFA10
NADH:ubiquinone oxidoreductase subunit A10
increases expression
EXP
clothianidin results in increased expression of NDUFA10 mRNA
CTD
PMID:31626844
NCBI chr 2:239,892,442...240,025,342
Ensembl chr 2:239,892,450...240,025,743
G
NECTIN4
nectin cell adhesion molecule 4
decreases expression
EXP
clothianidin results in decreased expression of NECTIN4 mRNA
CTD
PMID:35690182
NCBI chr 1:161,070,998...161,089,558
Ensembl chr 1:161,070,998...161,089,558
G
NEUROD4
neuronal differentiation 4
decreases expression
EXP
clothianidin results in decreased expression of NEUROD4 mRNA
CTD
PMID:31626844
NCBI chr12:55,019,974...55,030,017
Ensembl chr12:55,019,974...55,030,017
G
NGEF
neuronal guanine nucleotide exchange factor
increases expression
EXP
clothianidin results in increased expression of NGEF mRNA
CTD
PMID:31626844
NCBI chr 2:232,878,701...233,013,256
Ensembl chr 2:232,878,701...233,013,256
G
NGFR
nerve growth factor receptor
increases expression
EXP
clothianidin results in increased expression of NGFR mRNA
CTD
PMID:29044138
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NINL
ninein like
decreases expression
EXP
clothianidin results in decreased expression of NINL mRNA
CTD
PMID:35690182
NCBI chr20:25,452,697...25,585,531
Ensembl chr20:25,451,594...25,585,531
G
NLRP13
NLR family pyrin domain containing 13
decreases expression
EXP
clothianidin results in decreased expression of NLRP13 mRNA
CTD
PMID:31626844
NCBI chr19:55,891,692...55,932,336
Ensembl chr19:55,891,699...55,932,336
G
NOS2
nitric oxide synthase 2
increases expression
EXP
clothianidin results in increased expression of NOS2 mRNA
CTD
PMID:31626844
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NR0B2
nuclear receptor subfamily 0 group B member 2
multiple interactions decreases expression
EXP
[clothianidin co-treated with enilconazole] results in decreased expression of NR0B2 mRNA clothianidin results in decreased expression of NR0B2 mRNA
CTD
PMID:32201337
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NTN4
netrin 4
decreases expression
EXP
clothianidin results in decreased expression of NTN4 mRNA
CTD
PMID:31626844
NCBI chr12:95,657,807...95,791,155
Ensembl chr12:95,657,807...95,791,189
G
NTS
neurotensin
decreases expression
EXP
clothianidin results in decreased expression of NTS mRNA
CTD
PMID:31626844
NCBI chr12:85,874,295...85,882,992
Ensembl chr12:85,874,295...85,882,992
G
NXNL2
nucleoredoxin like 2
increases expression
EXP
clothianidin results in increased expression of NXNL2 mRNA
CTD
PMID:31626844
NCBI chr 9:88,535,178...88,584,510
Ensembl chr 9:88,534,033...88,584,274
G
NXPH2
neurexophilin 2
increases expression
EXP
clothianidin results in increased expression of NXPH2 mRNA
CTD
PMID:31626844
NCBI chr 2:138,669,157...138,780,390
Ensembl chr 2:138,669,157...138,780,390
G
OCRL
OCRL inositol polyphosphate-5-phosphatase
decreases expression
EXP
clothianidin results in decreased expression of OCRL mRNA
CTD
PMID:31626844
NCBI chr X:129,540,259...129,592,556
Ensembl chr X:129,539,849...129,592,561
G
OR1D4
olfactory receptor family 1 subfamily D member 4
increases expression
EXP
clothianidin results in increased expression of OR1D4 mRNA
CTD
PMID:31626844
NCBI chr17:3,240,676...3,241,614
Ensembl chr17:3,240,676...3,241,614
G
OR51E2
olfactory receptor family 51 subfamily E member 2
increases expression
EXP
clothianidin results in increased expression of OR51E2 mRNA
CTD
PMID:31626844
NCBI chr11:4,680,171...4,697,853
Ensembl chr11:4,680,171...4,697,854
G
OTUD6B
OTU deubiquitinase 6B
increases expression
EXP
clothianidin results in increased expression of OTUD6B mRNA
CTD
PMID:29044138
NCBI chr 8:91,070,344...91,087,093
Ensembl chr 8:91,070,196...91,087,095
G
OXER1
oxoeicosanoid receptor 1
decreases expression
EXP
clothianidin results in decreased expression of OXER1 mRNA
CTD
PMID:29044138
NCBI chr 2:42,762,499...42,764,135
Ensembl chr 2:42,762,499...42,764,135
G
PADI4
peptidyl arginine deiminase 4
increases expression
EXP
clothianidin results in increased expression of PADI4 mRNA
CTD
PMID:31626844
NCBI chr 1:17,308,197...17,364,004
Ensembl chr 1:17,308,195...17,364,004
G
PAGE5
PAGE family member 5
decreases expression
EXP
clothianidin results in decreased expression of PAGE5 mRNA
CTD
PMID:31626844
NCBI chr X:55,220,346...55,224,108
Ensembl chr X:55,220,346...55,224,108
G
PAK5
p21 (RAC1) activated kinase 5
decreases expression
EXP
clothianidin results in decreased expression of PAK5 mRNA; clothianidin results in decreased expression of PAK7 mRNA
CTD
PMID:31626844 PMID:35690182
NCBI chr20:9,537,370...9,839,076
Ensembl chr20:9,537,370...9,839,076
G
PAQR8
progestin and adipoQ receptor family member 8
decreases expression
EXP
clothianidin results in decreased expression of PAQR8 mRNA
CTD
PMID:29044138
NCBI chr 6:52,362,151...52,407,777
Ensembl chr 6:52,361,421...52,407,777
G
PBLD
phenazine biosynthesis like protein domain containing
decreases expression
EXP
clothianidin results in decreased expression of PBLD mRNA
CTD
PMID:31626844
NCBI chr10:68,282,660...68,332,928
Ensembl chr10:68,282,660...68,333,049
G
PCCA
propionyl-CoA carboxylase subunit alpha
decreases expression
EXP
clothianidin results in decreased expression of PCCA mRNA
CTD
PMID:32201337
NCBI chr13:100,089,093...100,530,435
Ensembl chr13:100,089,015...100,530,437
G
PCSK1
proprotein convertase subtilisin/kexin type 1
decreases expression
EXP
clothianidin results in decreased expression of PCSK1 mRNA
CTD
PMID:31626844
NCBI chr 5:96,390,333...96,433,248
Ensembl chr 5:96,390,333...96,434,143
G
PDE10A
phosphodiesterase 10A
decreases expression
EXP
clothianidin results in decreased expression of PDE10A mRNA
CTD
PMID:31626844
NCBI chr 6:165,327,289...165,988,052
Ensembl chr 6:165,327,287...165,988,117
G
PDE1C
phosphodiesterase 1C
increases expression
EXP
clothianidin results in increased expression of PDE1C mRNA
CTD
PMID:31626844
NCBI chr 7:31,616,777...32,428,224
Ensembl chr 7:31,751,179...32,428,131
G
PDE4DIP
phosphodiesterase 4D interacting protein
increases expression
EXP
clothianidin results in increased expression of PDE4DIP mRNA
CTD
PMID:31626844
NCBI chr 1:148,808,434...149,033,016
Ensembl chr 1:148,808,140...149,048,286
G
PDZD7
PDZ domain containing 7
decreases expression
EXP
clothianidin results in decreased expression of PDZD7 mRNA
CTD
PMID:29044138
NCBI chr10:101,007,679...101,031,129
Ensembl chr10:101,007,679...101,032,295
G
PELI2
pellino E3 ubiquitin protein ligase family member 2
decreases expression
EXP
clothianidin results in decreased expression of PELI2 mRNA
CTD
PMID:31626844
NCBI chr14:56,118,411...56,301,524
Ensembl chr14:56,117,814...56,301,524
G
PGAP6
post-GPI attachment to proteins 6
decreases expression
EXP
clothianidin results in decreased expression of PGAP6 mRNA
CTD
PMID:31626844
NCBI chr16:370,788...386,979
Ensembl chr16:370,788...387,113
G
PHETA2
PH domain containing endocytic trafficking adaptor 2
increases expression
EXP
clothianidin results in increased expression of FAM109B mRNA
CTD
PMID:31626844
NCBI chr22:42,074,248...42,079,438
Ensembl chr22:42,074,248...42,079,438
G
PIK3C2B
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta
decreases expression
EXP
clothianidin results in decreased expression of PIK3C2B mRNA
CTD
PMID:31626844
NCBI chr 1:204,422,633...204,494,805
Ensembl chr 1:204,422,628...204,494,805
G
PIP5K1C
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma
decreases expression
EXP
clothianidin results in decreased expression of PIP5K1C mRNA
CTD
PMID:31626844
NCBI chr19:3,630,183...3,700,468
Ensembl chr19:3,630,183...3,700,468
G
PIP5KL1
phosphatidylinositol-4-phosphate 5-kinase like 1
decreases expression
EXP
clothianidin results in decreased expression of PIP5KL1 mRNA
CTD
PMID:29044138
NCBI chr 9:127,920,881...127,930,777
Ensembl chr 9:127,920,881...127,930,785
G
PLA2G2A
phospholipase A2 group IIA
increases expression
EXP
clothianidin results in increased expression of PLA2G2A mRNA
CTD
PMID:31626844
NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416
G
PLBD1
phospholipase B domain containing 1
decreases expression
EXP
clothianidin results in decreased expression of PLBD1 mRNA
CTD
PMID:31626844
NCBI chr12:14,503,661...14,567,883
Ensembl chr12:14,503,661...14,567,883
G
PLCD1
phospholipase C delta 1
increases expression
EXP
clothianidin results in increased expression of PLCD1 mRNA
CTD
PMID:31626844
NCBI chr 3:38,007,496...38,029,642
Ensembl chr 3:38,007,496...38,029,642
G
PLCD3
phospholipase C delta 3
decreases expression
EXP
clothianidin results in decreased expression of PLCD3 mRNA
CTD
PMID:31626844
NCBI chr17:45,108,959...45,132,515
Ensembl chr17:45,108,959...45,133,354
G
PLCL1
phospholipase C like 1 (inactive)
decreases expression
EXP
clothianidin results in decreased expression of PLCL1 mRNA
CTD
PMID:31626844
NCBI chr 2:197,804,593...198,149,863
Ensembl chr 2:197,804,593...198,572,581
G
PLLP
plasmolipin
increases expression
EXP
clothianidin results in increased expression of PLLP mRNA
CTD
PMID:31626844
NCBI chr16:57,256,097...57,284,672
Ensembl chr16:57,248,547...57,284,672
G
PNPLA1
patatin like phospholipase domain containing 1
increases expression
EXP
clothianidin results in increased expression of PNPLA1 mRNA
CTD
PMID:31626844
NCBI chr 6:36,243,168...36,313,955
Ensembl chr 6:36,243,203...36,313,955
G
POLR2M
RNA polymerase II subunit M
decreases expression
EXP
clothianidin results in decreased expression of POLR2M mRNA
CTD
PMID:31626844
NCBI chr15:57,706,714...57,717,557
Ensembl chr15:57,706,695...57,782,762
G
PPP1R3C
protein phosphatase 1 regulatory subunit 3C
increases expression
EXP
clothianidin results in increased expression of PPP1R3C mRNA
CTD
PMID:29044138
NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071
G
PPP3CC
protein phosphatase 3 catalytic subunit gamma
increases expression
EXP
clothianidin results in increased expression of PPP3CC mRNA
CTD
PMID:31626844
NCBI chr 8:22,441,078...22,541,125
Ensembl chr 8:22,440,819...22,541,142
G
PRG3
proteoglycan 3, pro eosinophil major basic protein 2
increases expression
EXP
clothianidin results in increased expression of PRG3 mRNA
CTD
PMID:31626844
NCBI chr11:57,376,769...57,381,150
Ensembl chr11:57,376,769...57,381,150
G
PRKN
parkin RBR E3 ubiquitin protein ligase
decreases expression
EXP
clothianidin results in decreased expression of PARK2 mRNA
CTD
PMID:35690182
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
PRLR
prolactin receptor
decreases expression
EXP
clothianidin results in decreased expression of PRLR mRNA
CTD
PMID:29044138
NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,487
G
PRND
prion like protein doppel
increases expression
EXP
clothianidin results in increased expression of PRND mRNA
CTD
PMID:31626844
NCBI chr20:4,721,909...4,728,460
Ensembl chr20:4,721,909...4,728,460
G
PRODH2
proline dehydrogenase 2
increases expression
EXP
clothianidin results in increased expression of PRODH2 mRNA
CTD
PMID:31626844
NCBI chr19:35,799,988...35,812,845
Ensembl chr19:35,799,988...35,813,299
G
PRR5-ARHGAP8
PRR5-ARHGAP8 readthrough
increases expression
EXP
clothianidin results in increased expression of PRR5-ARHGAP8 mRNA
CTD
PMID:31626844
NCBI chr22:44,702,204...44,862,784
Ensembl chr22:44,702,233...44,862,706
G
PRR5L
proline rich 5 like
increases expression
EXP
clothianidin results in increased expression of PRR5L mRNA
CTD
PMID:31626844
NCBI chr11:36,296,288...36,465,204
Ensembl chr11:36,296,288...36,465,204
G
PRXL2B
peroxiredoxin like 2B
decreases expression
EXP
clothianidin results in decreased expression of PRXL2B mRNA
CTD
PMID:31626844
NCBI chr 1:2,586,523...2,591,468
Ensembl chr 1:2,586,491...2,591,469
G
PSEN1
presenilin 1
decreases expression
ISO
clothianidin results in decreased expression of PSEN1 mRNA
CTD
PMID:35264496
NCBI chr14:73,136,417...73,223,691
Ensembl chr14:73,136,418...73,223,691
G
PSMC6
proteasome 26S subunit, ATPase 6
decreases expression
EXP
clothianidin results in decreased expression of PSMC6 mRNA
CTD
PMID:31626844
NCBI chr14:52,707,200...52,728,590
Ensembl chr14:52,707,178...52,728,590
G
PSMD6-AS2
PSMD6 antisense RNA 2
decreases expression
EXP
clothianidin results in decreased expression of PSMD6-AS2 mRNA
CTD
PMID:29044138
NCBI chr 3:64,004,022...64,012,243
Ensembl chr 3:64,004,022...64,012,148
G
PTGFR
prostaglandin F receptor
decreases expression
EXP
clothianidin results in decreased expression of PTGFR mRNA
CTD
PMID:31626844
NCBI chr 1:78,490,974...78,540,701
Ensembl chr 1:78,303,884...78,540,701
G
PTPN3
protein tyrosine phosphatase non-receptor type 3
increases expression
EXP
clothianidin results in increased expression of PTPN3 mRNA
CTD
PMID:29044138
NCBI chr 9:109,375,694...109,538,420
Ensembl chr 9:109,375,466...109,498,313
G
PTPRB
protein tyrosine phosphatase receptor type B
decreases expression
EXP
clothianidin results in decreased expression of PTPRB mRNA
CTD
PMID:31626844
NCBI chr12:70,515,870...70,637,429
Ensembl chr12:70,515,870...70,637,440
G
PTPRO
protein tyrosine phosphatase receptor type O
decreases expression
EXP
clothianidin results in decreased expression of PTPRO mRNA
CTD
PMID:29044138
NCBI chr12:15,322,508...15,598,331
Ensembl chr12:15,322,257...15,602,175
G
QPCT
glutaminyl-peptide cyclotransferase
increases expression
EXP
clothianidin results in increased expression of QPCT mRNA
CTD
PMID:31626844
NCBI chr 2:37,344,630...37,373,322
Ensembl chr 2:37,342,827...37,373,322
G
RAET1L
retinoic acid early transcript 1L
increases expression
EXP
clothianidin results in increased expression of RAET1L mRNA
CTD
PMID:31626844
NCBI chr 6:150,018,334...150,025,532
Ensembl chr 6:150,018,334...150,025,532
G
RAG1
recombination activating 1
decreases expression
EXP
clothianidin results in decreased expression of RAG1 mRNA
CTD
PMID:31626844
NCBI chr11:36,510,353...36,579,762
Ensembl chr11:36,510,372...36,593,156
G
RAPGEFL1
Rap guanine nucleotide exchange factor like 1
decreases expression
EXP
clothianidin results in decreased expression of RAPGEFL1 mRNA
CTD
PMID:29044138
NCBI chr17:40,177,010...40,195,650
Ensembl chr17:40,177,010...40,195,656
G
RBM26
RNA binding motif protein 26
decreases expression
EXP
clothianidin results in decreased expression of RBM26 mRNA
CTD
PMID:31626844
NCBI chr13:79,311,827...79,406,255
Ensembl chr13:79,311,824...79,406,477
G
RBMS1
RNA binding motif single stranded interacting protein 1
decreases expression
EXP
clothianidin results in decreased expression of RBMS1 mRNA
CTD
PMID:31626844
NCBI chr 2:160,272,151...160,493,807
Ensembl chr 2:160,272,151...160,493,807
G
REG3G
regenerating family member 3 gamma
increases expression
EXP
clothianidin results in increased expression of REG3G mRNA
CTD
PMID:31626844
NCBI chr 2:79,025,702...79,028,501
Ensembl chr 2:79,025,686...79,028,505
G
RFESD
Rieske Fe-S domain containing
decreases expression
EXP
clothianidin results in decreased expression of RFESD mRNA
CTD
PMID:31626844
NCBI chr 5:95,646,777...95,658,082
Ensembl chr 5:95,646,777...95,684,773
G
RIIAD1
regulatory subunit of type II PKA R-subunit domain containing 1
decreases expression
EXP
clothianidin results in decreased expression of RIIAD1 mRNA
CTD
PMID:31626844
NCBI chr 1:151,711,551...151,729,805
Ensembl chr 1:151,710,433...151,729,805
G
RND1
Rho family GTPase 1
increases expression
EXP
clothianidin results in increased expression of RND1 mRNA
CTD
PMID:29044138
NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870
G
RP1L1
RP1 like 1
increases expression
EXP
clothianidin results in increased expression of RP1L1 mRNA
CTD
PMID:31626844
NCBI chr 8:10,606,349...10,655,143
Ensembl chr 8:10,606,349...10,712,187
G
RPS29
ribosomal protein S29
increases expression
EXP
clothianidin results in increased expression of RPS29 mRNA
CTD
PMID:31626844
NCBI chr14:49,570,988...49,598,710
Ensembl chr14:49,570,984...49,599,164
G
RRAD
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
EXP
clothianidin results in increased expression of RRAD mRNA
CTD
PMID:35690182
NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,685...66,925,535
G
S100A5
S100 calcium binding protein A5
decreases expression
EXP
clothianidin results in decreased expression of S100A5 mRNA
CTD
PMID:31626844
NCBI chr 1:153,537,147...153,543,685
Ensembl chr 1:153,537,147...153,541,765
G
SASH3
SAM and SH3 domain containing 3
increases expression
EXP
clothianidin results in increased expression of SASH3 mRNA
CTD
PMID:31626844
NCBI chr X:129,779,949...129,795,201
Ensembl chr X:129,779,949...129,795,201
G
SCN7A
sodium voltage-gated channel alpha subunit 7
decreases expression
EXP
clothianidin results in decreased expression of SCN7A mRNA
CTD
PMID:31626844
NCBI chr 2:166,403,573...166,494,249
Ensembl chr 2:166,403,573...166,611,482
G
SCNN1B
sodium channel epithelial 1 subunit beta
increases expression
EXP
clothianidin results in increased expression of SCNN1B mRNA
CTD
PMID:31626844
NCBI chr16:23,278,231...23,381,294
Ensembl chr16:23,278,231...23,381,294
G
SEMA3F
semaphorin 3F
decreases expression
EXP
clothianidin results in decreased expression of SEMA3F mRNA
CTD
PMID:31626844
NCBI chr 3:50,155,058...50,189,075
Ensembl chr 3:50,155,045...50,189,075
G
SERP1
stress associated endoplasmic reticulum protein 1
decreases expression
EXP
clothianidin results in decreased expression of SERP1 mRNA
CTD
PMID:31626844
NCBI chr 3:150,541,998...150,546,496
Ensembl chr 3:150,541,998...150,603,228
G
SERPINA13P
serpin family A member 13, pseudogene
increases expression
EXP
clothianidin results in increased expression of SERPINA13P mRNA
CTD
PMID:31626844
NCBI chr14:94,640,725...94,646,994
Ensembl chr14:94,640,725...94,646,994 Ensembl chr14:94,640,725...94,646,994
G
SERPINC1
serpin family C member 1
decreases expression
EXP
clothianidin results in decreased expression of SERPINC1 mRNA
CTD
PMID:31626844
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SERPINE1
serpin family E member 1
decreases expression
EXP
clothianidin results in decreased expression of SERPINE1 mRNA
CTD
PMID:31626844
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SGCD
sarcoglycan delta
increases expression
EXP
clothianidin results in increased expression of SGCD mRNA
CTD
PMID:31626844
NCBI chr 5:155,727,832...156,767,788
Ensembl chr 5:155,870,344...156,767,788
G
SGK2
serum/glucocorticoid regulated kinase 2
decreases expression
EXP
clothianidin results in decreased expression of SGK2 mRNA
CTD
PMID:29044138
NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237
G
SH3TC1
SH3 domain and tetratricopeptide repeats 1
increases expression
EXP
clothianidin results in increased expression of SH3TC1 mRNA
CTD
PMID:29044138
NCBI chr 4:8,182,072...8,241,103
Ensembl chr 4:8,182,072...8,241,803
G
SHANK2-AS3
SHANK2 antisense RNA 3
increases expression
EXP
clothianidin results in increased expression of SHANK2-AS3 mRNA
CTD
PMID:31626844
NCBI chr11:70,862,790...70,865,115
Ensembl chr11:70,862,790...70,865,115
G
SIPA1L2
signal induced proliferation associated 1 like 2
increases expression
EXP
clothianidin results in increased expression of SIPA1L2 mRNA
CTD
PMID:29044138
NCBI chr 1:232,397,965...232,630,496
Ensembl chr 1:232,397,965...232,630,571
G
SIRPB1
signal regulatory protein beta 1
increases expression
EXP
clothianidin results in increased expression of SIRPB1 mRNA
CTD
PMID:31626844
NCBI chr20:1,561,385...1,620,009
Ensembl chr20:1,561,385...1,620,061
G
SLC14A1
solute carrier family 14 member 1 (Kidd blood group)
decreases expression
EXP
clothianidin results in decreased expression of SLC14A1 mRNA
CTD
PMID:31626844
NCBI chr18:45,724,181...45,752,520
Ensembl chr18:45,687,025...45,752,520
G
SLC17A7
solute carrier family 17 member 7
decreases expression
EXP
clothianidin results in decreased expression of SLC17A7 mRNA
CTD
PMID:31626844
NCBI chr19:49,429,401...49,441,527
Ensembl chr19:49,429,401...49,442,360
G
SLC22A2
solute carrier family 22 member 2
decreases activity
EXP
clothianidin results in decreased activity of SLC22A2 protein
CTD
PMID:31364238
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
G
SLC22A6
solute carrier family 22 member 6
decreases activity
EXP
clothianidin results in decreased activity of SLC22A6 protein
CTD
PMID:31364238
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
decreases activity
EXP
clothianidin results in decreased activity of SLC22A8 protein
CTD
PMID:31364238
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
SLC28A1
solute carrier family 28 member 1
increases expression
EXP
clothianidin results in increased expression of SLC28A1 mRNA
CTD
PMID:31626844
NCBI chr15:84,884,662...84,975,649
Ensembl chr15:84,884,654...84,945,798
G
SLC2A14
solute carrier family 2 member 14
decreases expression
EXP
clothianidin results in decreased expression of SLC2A14 mRNA
CTD
PMID:35690182
NCBI chr12:7,812,514...7,891,196
Ensembl chr12:7,812,512...7,891,148
G
SLC38A9
solute carrier family 38 member 9
decreases expression
EXP
clothianidin results in decreased expression of SLC38A9 mRNA
CTD
PMID:31626844
NCBI chr 5:55,625,845...55,712,335
Ensembl chr 5:55,625,845...55,773,194
G
SLC45A2
solute carrier family 45 member 2
decreases expression
EXP
clothianidin results in decreased expression of SLC45A2 mRNA
CTD
PMID:31626844
NCBI chr 5:33,944,623...33,984,693
Ensembl chr 5:33,944,623...33,984,693
G
SLC47A2
solute carrier family 47 member 2
decreases activity
EXP
clothianidin results in decreased activity of SLC47A2 protein
CTD
PMID:31364238
NCBI chr17:19,678,317...19,718,979
Ensembl chr17:19,678,288...19,718,979
G
SLC48A1
solute carrier family 48 member 1
increases expression
EXP
clothianidin results in increased expression of SLC48A1 mRNA
CTD
PMID:31626844
NCBI chr12:47,753,934...47,782,751
Ensembl chr12:47,753,916...47,782,751
G
SLC6A1
solute carrier family 6 member 1
multiple interactions decreases expression
ISO
[enilconazole co-treated with clothianidin] results in decreased expression of SLC6A1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of SLC6A1 mRNA clothianidin results in decreased expression of SLC6A1 mRNA
CTD
PMID:33426623
NCBI chr 3:10,992,748...11,039,247
Ensembl chr 3:10,992,186...11,039,247
G
SLCO1C1
solute carrier organic anion transporter family member 1C1
increases expression
EXP
clothianidin results in increased expression of SLCO1C1 mRNA
CTD
PMID:31626844
NCBI chr12:20,695,332...20,753,386
Ensembl chr12:20,695,332...20,753,386
G
SMPD3
sphingomyelin phosphodiesterase 3
decreases expression
EXP
clothianidin results in decreased expression of SMPD3 mRNA
CTD
PMID:35690182
NCBI chr16:68,358,327...68,448,508
Ensembl chr16:68,358,327...68,448,508
G
SORBS1
sorbin and SH3 domain containing 1
increases expression
EXP
clothianidin results in increased expression of SORBS1 mRNA
CTD
PMID:31626844
NCBI chr10:95,311,773...95,561,371
Ensembl chr10:95,311,771...95,561,414
G
SPANXD
SPANX family member D
increases expression
EXP
clothianidin results in increased expression of SPANXD mRNA
CTD
PMID:31626844
NCBI chr X:141,697,411...141,698,739
Ensembl chr X:141,697,411...141,698,739
G
SPATA3
spermatogenesis associated 3
increases expression
EXP
clothianidin results in increased expression of SPATA3 mRNA
CTD
PMID:31626844
NCBI chr 2:230,996,121...231,020,109
Ensembl chr 2:230,990,324...231,025,055
G
SPIRE2
spire type actin nucleation factor 2
decreases expression
EXP
clothianidin results in decreased expression of SPIRE2 mRNA
CTD
PMID:29044138
NCBI chr16:89,828,475...89,871,319
Ensembl chr16:89,818,179...89,871,319
G
SRD5A2
steroid 5 alpha-reductase 2
increases expression
EXP
clothianidin results in increased expression of SRD5A2 mRNA
CTD
PMID:31626844
NCBI chr 2:31,522,480...31,663,009
Ensembl chr 2:31,522,480...31,580,938
G
SSPOP
SCO-spondin, pseudogene
decreases expression
EXP
clothianidin results in decreased expression of SSPOP mRNA
CTD
PMID:29044138
NCBI chr 7:149,776,042...149,833,965
Ensembl chr 7:149,776,042...149,833,829
G
STAC2
SH3 and cysteine rich domain 2
increases expression
EXP
clothianidin results in increased expression of STAC2 mRNA
CTD
PMID:31626844
NCBI chr17:39,210,541...39,225,945
Ensembl chr17:39,210,541...39,225,945
G
STEAP2
STEAP2 metalloreductase
increases expression
EXP
clothianidin results in increased expression of STEAP2 mRNA
CTD
PMID:31626844
NCBI chr 7:90,211,740...90,243,408
Ensembl chr 7:90,167,590...90,238,137
G
SUSD4
sushi domain containing 4
increases expression
EXP
clothianidin results in increased expression of SUSD4 mRNA
CTD
PMID:31626844
NCBI chr 1:223,220,831...223,365,235
Ensembl chr 1:223,220,819...223,364,233
G
SYCP2
synaptonemal complex protein 2
decreases expression
EXP
clothianidin results in decreased expression of SYCP2 mRNA
CTD
PMID:29044138
NCBI chr20:59,863,571...59,933,637
Ensembl chr20:59,863,564...59,933,655
G
SYNPO
synaptopodin
decreases expression
EXP
clothianidin results in decreased expression of SYNPO mRNA
CTD
PMID:29044138
NCBI chr 5:150,586,010...150,659,207
Ensembl chr 5:150,601,080...150,659,207
G
TACR1
tachykinin receptor 1
increases expression
EXP
clothianidin results in increased expression of TACR1 mRNA
CTD
PMID:31626844
NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520
G
TAF1L
TATA-box binding protein associated factor 1 like
decreases expression
EXP
clothianidin results in decreased expression of TAF1L mRNA
CTD
PMID:31626844
NCBI chr 9:32,629,454...32,635,669
Ensembl chr 9:32,629,454...32,635,669
G
TAFA2
TAFA chemokine like family member 2
decreases expression
EXP
clothianidin results in decreased expression of FAM19A2 mRNA
CTD
PMID:31626844
NCBI chr12:61,708,273...62,260,034
Ensembl chr12:61,708,273...62,279,150
G
TAFA5
TAFA chemokine like family member 5
increases expression
EXP
clothianidin results in increased expression of FAM19A5 mRNA
CTD
PMID:31626844
NCBI chr22:48,489,553...48,751,932
Ensembl chr22:48,489,553...48,850,912
G
TBX2
T-box transcription factor 2
increases expression
EXP
clothianidin results in increased expression of TBX2 mRNA
CTD
PMID:29044138
NCBI chr17:61,399,843...61,409,466
Ensembl chr17:61,399,843...61,409,466
G
TCP10L2
t-complex 10 like 2 (pseudogene)
increases expression
EXP
clothianidin results in increased expression of TCP10L2 mRNA
CTD
PMID:31626844
NCBI chr 6:167,170,619...167,196,751
Ensembl chr 6:167,172,145...167,196,679
G
TECPR1
tectonin beta-propeller repeat containing 1
decreases expression
EXP
clothianidin results in decreased expression of TECPR1 mRNA
CTD
PMID:31626844
NCBI chr 7:98,214,624...98,252,232
Ensembl chr 7:98,214,624...98,252,232
G
TEF
TEF transcription factor, PAR bZIP family member
increases expression
EXP
clothianidin results in increased expression of TEF mRNA
CTD
PMID:31626844
NCBI chr22:41,367,455...41,399,326
Ensembl chr22:41,367,333...41,399,326
G
TGFBI
transforming growth factor beta induced
increases expression
EXP
clothianidin results in increased expression of TGFBI mRNA
CTD
PMID:31626844
NCBI chr 5:136,028,988...136,063,818
Ensembl chr 5:136,028,988...136,063,818
G
TGM5
transglutaminase 5
decreases expression
EXP
clothianidin results in decreased expression of TGM5 mRNA
CTD
PMID:29044138
NCBI chr15:43,232,590...43,266,928
Ensembl chr15:43,232,590...43,266,928
G
THAP9
THAP domain containing 9
increases expression
EXP
clothianidin results in increased expression of THAP9 mRNA
CTD
PMID:31626844
NCBI chr 4:82,900,735...82,919,969
Ensembl chr 4:82,900,684...82,919,969
G
THRSP
thyroid hormone responsive
decreases expression
EXP
clothianidin results in decreased expression of THRSP mRNA
CTD
PMID:35690182
NCBI chr11:78,063,861...78,068,351
Ensembl chr11:78,063,861...78,068,351
G
TICAM1
TIR domain containing adaptor molecule 1
increases expression
ISO
clothianidin results in increased expression of TICAM1 mRNA
CTD
PMID:35264496
NCBI chr19:4,815,932...4,831,712
Ensembl chr19:4,815,932...4,831,712
G
TIFA
TRAF interacting protein with forkhead associated domain
increases expression
EXP
clothianidin results in increased expression of TIFA mRNA
CTD
PMID:31626844
NCBI chr 4:112,274,537...112,285,904
Ensembl chr 4:112,272,968...112,285,955
G
TLCD4
TLC domain containing 4
increases expression
EXP
clothianidin results in increased expression of TLCD4 mRNA
CTD
PMID:29044138
NCBI chr 1:95,092,517...95,197,607
Ensembl chr 1:95,117,355...95,197,607
G
TLR2
toll like receptor 2
increases expression
ISO
clothianidin results in increased expression of TLR2 mRNA
CTD
PMID:35264496
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLX3
T cell leukemia homeobox 3
decreases expression
EXP
clothianidin results in decreased expression of TLX3 mRNA
CTD
PMID:31626844
NCBI chr 5:171,309,248...171,312,139
Ensembl chr 5:171,309,248...171,312,139
G
TMEM273
transmembrane protein 273
increases expression
EXP
clothianidin results in increased expression of TMEM273 mRNA
CTD
PMID:31626844
NCBI chr10:49,154,736...49,188,391
Ensembl chr10:49,154,725...49,188,585
G
TMEM38A
transmembrane protein 38A
decreases expression
EXP
clothianidin results in decreased expression of TMEM38A mRNA
CTD
PMID:29044138
NCBI chr19:16,661,139...16,690,023
Ensembl chr19:16,661,139...16,690,023
G
TMEM71
transmembrane protein 71
decreases expression
EXP
clothianidin results in decreased expression of TMEM71 mRNA
CTD
PMID:31626844
NCBI chr 8:132,705,839...132,775,999
Ensembl chr 8:132,685,007...132,760,712
G
TMT1A
thiol methyltransferase 1A
decreases expression
EXP
clothianidin results in decreased expression of TMT1A mRNA
CTD
PMID:29044138
NCBI chr12:50,925,015...50,932,508
Ensembl chr12:50,923,472...50,932,510
G
TNF
tumor necrosis factor
multiple interactions
EXP
clothianidin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; clothianidin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:29044138
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF11B
TNF receptor superfamily member 11b
decreases expression
EXP
clothianidin results in decreased expression of TNFRSF11B mRNA
CTD
PMID:31626844
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
TNXB
tenascin XB
decreases expression
EXP
clothianidin results in decreased expression of TNXB mRNA
CTD
PMID:29044138
NCBI chr 6:32,041,153...32,109,338
Ensembl chr 6:32,041,153...32,115,334
G
TPM1
tropomyosin 1
increases expression
EXP
clothianidin results in increased expression of TPM1 mRNA
CTD
PMID:29044138
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
G
TRAF4
TNF receptor associated factor 4
increases expression
EXP
clothianidin results in increased expression of TRAF4 mRNA
CTD
PMID:29044138
NCBI chr17:28,744,011...28,750,956
Ensembl chr17:28,744,011...28,750,956
G
TRAF6
TNF receptor associated factor 6
decreases expression
EXP
clothianidin results in decreased expression of TRAF6 mRNA
CTD
PMID:29044138
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
G
TRAPPC4
trafficking protein particle complex subunit 4
increases expression
EXP
clothianidin results in increased expression of TRAPPC4 mRNA
CTD
PMID:31626844
NCBI chr11:119,018,766...119,024,134
Ensembl chr11:119,018,763...119,025,454
G
TRIM37
tripartite motif containing 37
decreases expression
EXP
clothianidin results in decreased expression of TRIM37 mRNA
CTD
PMID:31626844
NCBI chr17:58,967,201...59,106,880
Ensembl chr17:58,982,638...59,106,921
G
TRMT44
tRNA methyltransferase 44 homolog
increases expression
EXP
clothianidin results in increased expression of TRMT44 mRNA
CTD
PMID:31626844
NCBI chr 4:8,440,777...8,516,950
Ensembl chr 4:8,436,140...8,493,531
G
TSSK6
testis specific serine kinase 6
decreases expression
EXP
clothianidin results in decreased expression of TSSK6 mRNA
CTD
PMID:31626844
NCBI chr19:19,514,219...19,515,548
Ensembl chr19:19,512,418...19,515,548
G
TTC28
tetratricopeptide repeat domain 28
decreases expression
EXP
clothianidin results in decreased expression of TTC28 mRNA
CTD
PMID:31626844
NCBI chr22:27,978,014...28,679,840
Ensembl chr22:27,978,014...28,679,840
G
TTC33
tetratricopeptide repeat domain 33
decreases expression
EXP
clothianidin results in decreased expression of TTC33 mRNA
CTD
PMID:31626844
NCBI chr 5:40,711,576...40,755,961
Ensembl chr 5:40,512,333...40,755,963
G
TTC8
tetratricopeptide repeat domain 8
decreases expression
EXP
clothianidin results in decreased expression of TTC8 mRNA
CTD
PMID:31626844
NCBI chr14:88,824,153...88,881,079
Ensembl chr14:88,824,153...88,881,078
G
TUBGCP3
tubulin gamma complex component 3
increases expression
EXP
clothianidin results in increased expression of TUBGCP3 mRNA
CTD
PMID:31626844
NCBI chr13:112,485,011...112,605,630
Ensembl chr13:112,485,011...112,588,205
G
TXNDC2
thioredoxin domain containing 2
increases expression
EXP
clothianidin results in increased expression of TXNDC2 mRNA
CTD
PMID:31626844
NCBI chr18:9,885,973...9,889,275
Ensembl chr18:9,885,766...9,889,275
G
UBAP1L
ubiquitin associated protein 1 like
decreases expression increases expression
EXP
clothianidin results in decreased expression of UBAP1L mRNA clothianidin results in increased expression of UBAP1L mRNA
CTD
PMID:29044138 PMID:31626844
NCBI chr15:65,092,760...65,115,200
Ensembl chr15:65,092,760...65,115,200
G
UNC119B
unc-119 lipid binding chaperone B
increases expression
EXP
clothianidin results in increased expression of UNC119B mRNA
CTD
PMID:31626844
NCBI chr12:120,710,458...120,723,640
Ensembl chr12:120,710,458...120,723,640
G
USP43
ubiquitin specific peptidase 43
decreases expression
EXP
clothianidin results in decreased expression of USP43 mRNA
CTD
PMID:31626844
NCBI chr17:9,645,260...9,729,687
Ensembl chr17:9,644,698...9,729,687
G
UTRN
utrophin
decreases expression
EXP
clothianidin results in decreased expression of UTRN mRNA
CTD
PMID:31626844
NCBI chr 6:144,285,335...144,853,034
Ensembl chr 6:144,285,335...144,853,034
G
VAMP8
vesicle associated membrane protein 8
increases expression
EXP
clothianidin results in increased expression of VAMP8 mRNA
CTD
PMID:31626844
NCBI chr 2:85,577,586...85,582,031
Ensembl chr 2:85,561,562...85,582,031
G
VEGFD
vascular endothelial growth factor D
decreases expression
EXP
clothianidin results in decreased expression of VEGFD mRNA
CTD
PMID:31626844
NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413
G
VPS8
VPS8 subunit of CORVET complex
decreases expression
EXP
clothianidin results in decreased expression of VPS8 mRNA
CTD
PMID:31626844
NCBI chr 3:184,812,166...185,052,614
Ensembl chr 3:184,812,143...185,052,614
G
WASHC4
WASH complex subunit 4
increases expression
EXP
clothianidin results in increased expression of WASHC4 mRNA
CTD
PMID:31626844
NCBI chr12:105,107,731...105,169,130
Ensembl chr12:105,107,324...105,169,130
G
WHRN
whirlin
increases expression
EXP
clothianidin results in increased expression of WHRN mRNA
CTD
PMID:31626844
NCBI chr 9:114,402,080...114,505,473
Ensembl chr 9:114,402,080...114,505,473
G
WNT7B
Wnt family member 7B
decreases expression
EXP
clothianidin results in decreased expression of WNT7B mRNA
CTD
PMID:35690182
NCBI chr22:45,920,366...45,977,162
Ensembl chr22:45,920,366...45,977,162
G
XAGE3
X antigen family member 3
increases expression
EXP
clothianidin results in increased expression of XAGE3 mRNA
CTD
PMID:31626844
NCBI chr X:52,862,528...52,868,083
Ensembl chr X:52,862,525...52,868,083
G
YPEL2
yippee like 2
increases expression
EXP
clothianidin results in increased expression of YPEL2 mRNA
CTD
PMID:31626844
NCBI chr17:59,331,655...59,401,729
Ensembl chr17:59,331,655...59,401,729
G
YPEL3
yippee like 3
decreases expression
EXP
clothianidin results in decreased expression of YPEL3 mRNA
CTD
PMID:29044138
NCBI chr16:30,092,314...30,096,213
Ensembl chr16:30,092,314...30,096,915
G
ZBTB45
zinc finger and BTB domain containing 45
decreases expression
EXP
clothianidin results in decreased expression of ZBTB45 mRNA
CTD
PMID:31626844
NCBI chr19:58,513,530...58,542,718
Ensembl chr19:58,513,530...58,538,911
G
ZCCHC13
zinc finger CCHC-type containing 13
decreases expression
EXP
clothianidin results in decreased expression of ZCCHC13 mRNA
CTD
PMID:31626844
NCBI chr X:74,304,180...74,305,034
Ensembl chr X:74,304,180...74,305,034
G
ZDHHC11B
zinc finger DHHC-type containing 11B
decreases expression
EXP
clothianidin results in decreased expression of ZDHHC11B mRNA
CTD
PMID:31626844
NCBI chr 5:710,355...784,729
Ensembl chr 5:710,355...784,729
G
ZKSCAN7
zinc finger with KRAB and SCAN domains 7
increases expression
EXP
clothianidin results in increased expression of ZKSCAN7 mRNA
CTD
PMID:31626844
NCBI chr 3:44,555,193...44,583,483
Ensembl chr 3:44,555,193...44,594,173
G
ZNF141
zinc finger protein 141
decreases expression
EXP
clothianidin results in decreased expression of ZNF141 mRNA
CTD
PMID:31626844
NCBI chr 4:337,814...384,868
Ensembl chr 4:337,814...384,868
G
ZNF18
zinc finger protein 18
decreases expression
EXP
clothianidin results in decreased expression of ZNF18 mRNA
CTD
PMID:31626844
NCBI chr17:11,977,439...12,021,527
Ensembl chr17:11,977,439...11,997,475
G
ZNF20
zinc finger protein 20
increases expression
EXP
clothianidin results in increased expression of ZNF20 mRNA
CTD
PMID:31626844
NCBI chr19:12,131,350...12,140,350
Ensembl chr19:12,092,843...12,140,355
G
ZNF200
zinc finger protein 200
decreases expression
EXP
clothianidin results in decreased expression of ZNF200 mRNA
CTD
PMID:31626844
NCBI chr16:3,222,325...3,235,158
Ensembl chr16:3,222,325...3,236,221
G
ZNF219
zinc finger protein 219
decreases expression
EXP
clothianidin results in decreased expression of ZNF219 mRNA
CTD
PMID:29044138
NCBI chr14:21,090,077...21,104,722
Ensembl chr14:21,090,077...21,104,722
G
ZNF273
zinc finger protein 273
decreases expression
EXP
clothianidin results in decreased expression of ZNF273 mRNA
CTD
PMID:31626844
NCBI chr 7:64,877,603...64,937,316
Ensembl chr 7:64,870,172...64,930,981
G
ZNF467
zinc finger protein 467
increases expression
EXP
clothianidin results in increased expression of ZNF467 mRNA
CTD
PMID:31626844
NCBI chr 7:149,764,182...149,776,530
Ensembl chr 7:149,764,182...149,773,588
G
ZNF470
zinc finger protein 470
increases expression
EXP
clothianidin results in increased expression of ZNF470 mRNA
CTD
PMID:31626844
NCBI chr19:56,567,468...56,582,894
Ensembl chr19:56,567,468...56,588,911
G
ZNF501
zinc finger protein 501
decreases expression
EXP
clothianidin results in decreased expression of ZNF501 mRNA
CTD
PMID:31626844
NCBI chr 3:44,729,635...44,737,083
Ensembl chr 3:44,729,596...44,737,083
G
ZNF502
zinc finger protein 502
increases expression
EXP
clothianidin results in increased expression of ZNF502 mRNA
CTD
PMID:31626844
NCBI chr 3:44,712,660...44,723,831
Ensembl chr 3:44,712,643...44,723,831
G
ZNF521
zinc finger protein 521
decreases expression
EXP
clothianidin results in decreased expression of ZNF521 mRNA
CTD
PMID:31626844
NCBI chr18:25,061,924...25,352,166
Ensembl chr18:25,061,924...25,352,190
G
ZNF627
zinc finger protein 627
increases expression
EXP
clothianidin results in increased expression of ZNF627 mRNA
CTD
PMID:31626844
NCBI chr19:11,597,483...11,619,161
Ensembl chr19:11,559,374...11,619,161
G
ZNF653
zinc finger protein 653
decreases expression
EXP
clothianidin results in decreased expression of ZNF653 mRNA
CTD
PMID:31626844
NCBI chr19:11,483,429...11,505,839
Ensembl chr19:11,483,427...11,505,839
G
ZNF784
zinc finger protein 784
increases expression
EXP
clothianidin results in increased expression of ZNF784 mRNA
CTD
PMID:31626844
NCBI chr19:55,620,741...55,624,566
Ensembl chr19:55,620,741...55,624,566
G
ZNF875
zinc finger protein 875
increases expression
EXP
clothianidin results in increased expression of HKR1 mRNA
CTD
PMID:31626844
NCBI chr19:37,312,837...37,364,455
Ensembl chr19:37,312,837...37,369,365
G
ZSWIM4
zinc finger SWIM-type containing 4
decreases expression
EXP
clothianidin results in decreased expression of ZSWIM4 mRNA
CTD
PMID:31626844
NCBI chr19:13,795,443...13,832,254
Ensembl chr19:13,795,443...13,832,254
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO
dinotefuran results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein]; dinotefuran results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]
CTD
PMID:16981889 PMID:25459289
NCBI chr 1:154,567,778...154,580,013
Ensembl chr 1:154,567,778...154,580,013
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of ABL1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ABL1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ABL1 mRNA
CTD
PMID:19840844
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675
G
ACOX2
acyl-CoA oxidase 2
decreases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of ACOX2 mRNA
CTD
PMID:15120970
NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283
G
ADAM10
ADAM metallopeptidase domain 10
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of ADAM10 mRNA
CTD
PMID:12634122
NCBI chr15:58,588,809...58,749,707
Ensembl chr15:58,588,809...58,749,791
G
AGT
angiotensinogen
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of AGT mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of AGT mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of AGT mRNA
CTD
PMID:19840844
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AIFM1
apoptosis inducing factor mitochondria associated 1
multiple interactions increases localization
EXP
benzamide inhibits the reaction [Methylnitronitrosoguanidine results in increased localization of AIFM1 protein]; phenanthridone inhibits the reaction [Methylnitronitrosoguanidine results in increased localization of AIFM1 protein]
CTD
PMID:15589979
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
G
AKT1
AKT serine/threonine kinase 1
multiple interactions increases expression
ISO
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of AKT1 mRNA]
CTD
PMID:35103375
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALB
albumin
decreases secretion
ISO
Methylnitronitrosoguanidine results in decreased secretion of ALB protein
CTD
PMID:15772367
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of ALDH1A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of ALDH1A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of ALDH1A1 mRNA
CTD
PMID:19840844
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
ALPL
alkaline phosphatase, biomineralization associated
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of ALPL mRNA
CTD
PMID:12634122
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
G
AMBP
alpha-1-microglobulin/bikunin precursor
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of AMBP mRNA
CTD
PMID:12773770
NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
G
ANXA5
annexin A5
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ANXA5 mRNA
CTD
PMID:19840844
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
G
APAF1
apoptotic peptidase activating factor 1
affects response to substance decreases expression multiple interactions
ISO
APAF1 protein affects the susceptibility to Methylnitronitrosoguanidine Methylnitronitrosoguanidine results in decreased expression of APAF1 protein Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of APAF1 protein]
CTD
PMID:16019050 PMID:20434464
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,290...98,735,433
G
APC
APC regulator of WNT signaling pathway
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of APC mRNA
CTD
PMID:12634122
NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,518...112,846,239
G
APP
amyloid beta precursor protein
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of APP mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of APP mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of APP mRNA
CTD
PMID:19840844
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
ARAF
A-Raf proto-oncogene, serine/threonine kinase
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of ARAF mRNA
CTD
PMID:12634122
NCBI chr X:47,561,205...47,571,908
Ensembl chr X:47,561,205...47,571,908
G
ATM
ATM serine/threonine kinase
increases response to substance
ISO
ATM gene mutant form results in increased susceptibility to Methylnitronitrosoguanidine
CTD
PMID:15010311
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
G
ATP1B3
ATPase Na+/K+ transporting subunit beta 3
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of ATP1B3 mRNA
CTD
PMID:12634122
NCBI chr 3:141,876,643...141,926,549
Ensembl chr 3:141,876,124...141,926,549
G
ATR
ATR serine/threonine kinase
multiple interactions
EXP
ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein]
CTD
PMID:26921499
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
G
AXL
AXL receptor tyrosine kinase
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of AXL mRNA
CTD
PMID:12634122
NCBI chr19:41,219,223...41,261,766
Ensembl chr19:41,219,223...41,261,766
G
BAD
BCL2 associated agonist of cell death
decreases expression decreases phosphorylation multiple interactions
ISO EXP
Methylnitronitrosoguanidine results in decreased expression of BAD mRNA Methylnitronitrosoguanidine results in decreased phosphorylation of BAD protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of BAD protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA]
CTD
PMID:17828454 PMID:20434464
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAG1
BAG cochaperone 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of BAG1 mRNA
CTD
PMID:12634122
NCBI chr 9:33,252,471...33,264,708
Ensembl chr 9:33,247,820...33,264,720
G
BAK1
BCL2 antagonist/killer 1
multiple interactions
EXP
BAK1 protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib]
CTD
PMID:18376143
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions decreases expression
ISO EXP
[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BAX protein; corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein] Methylnitronitrosoguanidine results in decreased expression of BAX mRNA; Methylnitronitrosoguanidine results in decreased expression of BAX protein Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein] BAX protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib]
CTD
PMID:16030430 PMID:18376143 PMID:20434464 PMID:35103375
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCAT2
branched chain amino acid transaminase 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BCAT2 mRNA
CTD
PMID:19840844
NCBI chr19:48,795,064...48,811,029
Ensembl chr19:48,795,062...48,811,029
G
BCL2
BCL2 apoptosis regulator
decreases expression increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in decreased expression of BCL2 protein Methylnitronitrosoguanidine results in increased expression of BCL2 protein Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA; Methylnitronitrosoguanidine results in increased expression of BCL2 protein Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein] [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein; [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein]; Lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]
CTD
PMID:16019050 PMID:16030430 PMID:20434464 PMID:35103375
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
multiple interactions increases expression
EXP ISO
BCL2L1 protein results in decreased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA]
CTD
PMID:18376143 PMID:20434464
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BCL2L11
BCL2 like 11
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein]
CTD
PMID:16030430
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
G
BDNF
brain derived neurotrophic factor
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of BDNF mRNA
CTD
PMID:15120970
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BGN
biglycan
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of BGN mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of BGN mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BGN mRNA
CTD
PMID:19840844
NCBI chr X:153,494,980...153,509,546
Ensembl chr X:153,494,980...153,509,546
G
BID
BH3 interacting domain death agonist
multiple interactions decreases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA]
CTD
PMID:20434464
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
G
BIRC2
baculoviral IAP repeat containing 2
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of BIRC2 mRNA
CTD
PMID:12634122
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
G
BLVRB
biliverdin reductase B
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BLVRB mRNA
CTD
PMID:19840844
NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
G
BMP4
bone morphogenetic protein 4
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of BMP4 mRNA
CTD
PMID:12773770
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
BRCA1
BRCA1 DNA repair associated
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of BRCA1 mRNA
CTD
PMID:12634122
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
G
BRCA2
BRCA2 DNA repair associated
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of BRCA2 mRNA
CTD
PMID:12634122
NCBI chr13:32,315,508...32,400,268
Ensembl chr13:32,315,086...32,400,268
G
BSG
basigin (Ok blood group)
increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in increased expression of BSG mRNA corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BSG mRNA]
CTD
PMID:35103375
NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494
G
BTG2
BTG anti-proliferation factor 2
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of BTG2 protein
CTD
PMID:24821435
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
C1QB
complement C1q B chain
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of C1QB mRNA
CTD
PMID:15120970
NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637
G
C1S
complement C1s
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of C1S mRNA
CTD
PMID:15120970
NCBI chr12:7,060,718...7,071,032
Ensembl chr12:6,988,259...7,071,032
G
CALM1
calmodulin 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CALM1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CALM1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CALM1 mRNA
CTD
PMID:19840844
NCBI chr14:90,396,502...90,408,268
Ensembl chr14:90,396,502...90,408,268
G
CASP3
caspase 3
increases activity decreases expression multiple interactions
EXP ISO
Methylnitronitrosoguanidine results in increased activity of CASP3 protein Methylnitronitrosoguanidine results in decreased expression of CASP3 protein Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA; Methylnitronitrosoguanidine results in decreased expression of CASP3 protein Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [Methylnitronitrosoguanidine results in increased activity of CASP3 protein] [Methylnitronitrosoguanidine co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased activity of CASP3 protein; [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP3 protein; [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP3 protein]; corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein]
CTD
PMID:15589979 PMID:16019050 PMID:16030430 PMID:17428624 PMID:20434464 PMID:24476502 PMID:35103375 More...
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP4
caspase 4
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of CASP4 mRNA
CTD
PMID:12634122
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
G
CASP8
caspase 8
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein; [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein]; lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein]; S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein]
CTD
PMID:16030430
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
increases activity decreases expression multiple interactions
EXP ISO
Methylnitronitrosoguanidine results in increased activity of CASP9 protein Methylnitronitrosoguanidine results in decreased expression of CASP9 protein corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein]
CTD
PMID:15589979 PMID:16019050 PMID:20434464 PMID:35103375
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CAT
catalase
multiple interactions decreases activity
ISO
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased activity of CAT protein]
CTD
PMID:35103375
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CBX5
chromobox 5
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of CBX5 mRNA
CTD
PMID:12634122
NCBI chr12:54,230,942...54,280,122
Ensembl chr12:54,230,942...54,280,133
G
CCNA1
cyclin A1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of CCNA1 mRNA
CTD
PMID:12634122
NCBI chr13:36,431,517...36,442,870
Ensembl chr13:36,431,520...36,442,870
G
CCNB1
cyclin B1
multiple interactions decreases expression increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCNB1 mRNA] Methylnitronitrosoguanidine results in decreased expression of CCNB1 mRNA [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCNB1 mRNA
CTD
PMID:11516527 PMID:12135628 PMID:19851710
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCND1
cyclin D1
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA] [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCND1 protein Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA; Methylnitronitrosoguanidine results in increased expression of CCND1 protein
CTD
PMID:12135628 PMID:19851710 PMID:21628965
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCNG1
cyclin G1
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of CCNG1 mRNA
CTD
PMID:11516527
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
G
CCNH
cyclin H
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of CCNH mRNA
CTD
PMID:12634122
NCBI chr 5:87,311,471...87,412,930
Ensembl chr 5:87,318,416...87,413,029
G
CCT2
chaperonin containing TCP1 subunit 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CCT2 mRNA
CTD
PMID:19840844
NCBI chr12:69,585,459...69,601,570
Ensembl chr12:69,585,426...69,601,570
G
CD59
CD59 molecule (CD59 blood group)
increases mutagenesis
EXP
Methylnitronitrosoguanidine results in increased mutagenesis of CD59 protein
CTD
PMID:17045307
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
CD9
CD9 molecule
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CD9 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CD9 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD9 mRNA
CTD
PMID:19840844
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
G
CDH1
cadherin 1
multiple interactions decreases expression
ISO
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 protein]
CTD
PMID:28428697
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CDH8
cadherin 8
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of CDH8 mRNA
CTD
PMID:12634122
NCBI chr16:61,647,250...62,036,438
Ensembl chr16:61,647,242...62,037,035
G
CDK4
cyclin dependent kinase 4
multiple interactions increases expression
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CDK4 protein Methylnitronitrosoguanidine results in increased expression of CDK4 protein
CTD
PMID:12135628 PMID:21628965
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
G
CDK5
cyclin dependent kinase 5
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of CDK5 mRNA
CTD
PMID:12634122
NCBI chr 7:151,053,815...151,057,897
Ensembl chr 7:151,053,815...151,057,897
G
CDKN1A
cyclin dependent kinase inhibitor 1A
decreases expression multiple interactions
EXP ISO
Methylnitronitrosoguanidine results in decreased expression of CDKN1A mRNA Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein]
CTD
PMID:12634122 PMID:19851710
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1B
cyclin dependent kinase inhibitor 1B
decreases expression multiple interactions increases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein]; Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA]
CTD
PMID:11516527 PMID:12135628
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CEP43
centrosomal protein 43
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of CEP43 mRNA
CTD
PMID:12634122
NCBI chr 6:166,999,397...167,052,718
Ensembl chr 6:166,999,174...167,052,718
G
CHEK1
checkpoint kinase 1
multiple interactions
EXP
CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]
CTD
PMID:26921499
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
G
CHEK2
checkpoint kinase 2
multiple interactions
EXP
CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein]
CTD
PMID:26921499
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
G
CKB
creatine kinase B
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of CKB mRNA
CTD
PMID:12634122
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
G
CLTA
clathrin light chain A
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CLTA mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CLTA mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CLTA mRNA
CTD
PMID:19840844
NCBI chr 9:36,190,874...36,212,059
Ensembl chr 9:36,190,856...36,304,781
G
COL1A2
collagen type I alpha 2 chain
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL1A2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL1A2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL1A2 mRNA
CTD
PMID:19840844
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
G
COL6A1
collagen type VI alpha 1 chain
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL6A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL6A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL6A1 mRNA
CTD
PMID:19840844
NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,770...46,005,050
G
COL8A1
collagen type VIII alpha 1 chain
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of COL8A1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of COL8A1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of COL8A1 mRNA
CTD
PMID:19840844
NCBI chr 3:99,638,594...99,799,217
Ensembl chr 3:99,638,475...99,799,226
G
COX6A1
cytochrome c oxidase subunit 6A1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of COX6A1 mRNA
CTD
PMID:19840844
NCBI chr12:120,438,113...120,440,730
Ensembl chr12:120,438,090...120,440,737
G
COX8A
cytochrome c oxidase subunit 8A
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of COX8A mRNA
CTD
PMID:19840844
NCBI chr11:63,974,620...63,976,543
Ensembl chr11:63,974,620...63,976,543
G
CTNNB1
catenin beta 1
increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA]
CTD
PMID:28428697
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CTSB
cathepsin B
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of CTSB mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of CTSB mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CTSB mRNA
CTD
PMID:19840844
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CTSL
cathepsin L
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CTSL mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CTSL mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CTSL mRNA
CTD
PMID:19840844
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
CXCL12
C-X-C motif chemokine ligand 12
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CXCL12 mRNA
CTD
PMID:19840844
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
G
CXCR4
C-X-C motif chemokine receptor 4
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of CXCR4 mRNA
CTD
PMID:12634122
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
CYB561D2
cytochrome b561 family member D2
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of CYB561D2 mRNA
CTD
PMID:12634122
NCBI chr 3:50,350,862...50,368,197
Ensembl chr 3:50,350,845...50,358,460
G
CYCS
cytochrome c, somatic
multiple interactions decreases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS protein] Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA; Methylnitronitrosoguanidine results in decreased expression of CYCS protein
CTD
PMID:20434464
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
DAB2
DAB adaptor protein 2
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of DAB2 mRNA
CTD
PMID:12634122 PMID:12773770
NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300
G
DCN
decorin
decreases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of DCN mRNA
CTD
PMID:15120970
NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
G
DEAF1
DEAF1 transcription factor
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of DEAF1 mRNA
CTD
PMID:12634122
NCBI chr11:644,220...707,083
Ensembl chr11:644,233...707,118
G
DEK
DEK proto-oncogene
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of DEK mRNA
CTD
PMID:12634122
NCBI chr 6:18,223,860...18,264,530
Ensembl chr 6:18,223,860...18,264,548
G
DLG1
discs large MAGUK scaffold protein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of DLG1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of DLG1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of DLG1 mRNA
CTD
PMID:19840844
NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330
G
DSTN
destrin, actin depolymerizing factor
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of DSTN mRNA
CTD
PMID:12634122
NCBI chr20:17,570,075...17,609,919
Ensembl chr20:17,570,075...17,609,919
G
DUT
deoxyuridine triphosphatase
affects localization increases secretion
EXP
Methylnitronitrosoguanidine affects the localization of DUT protein Methylnitronitrosoguanidine results in increased secretion of DUT protein
CTD
PMID:21658424
NCBI chr15:48,331,095...48,343,373
Ensembl chr15:48,331,011...48,343,373
G
E2F1
E2F transcription factor 1
multiple interactions increases expression
EXP
ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; E2F1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein results in increased expression of RRM2 mRNA]
CTD
PMID:26921499
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
E2F3
E2F transcription factor 3
multiple interactions
EXP
[[Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA] inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; [Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; CHIR-124 inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; E2F3 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]]
CTD
PMID:26921499
NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714
G
EGF
epidermal growth factor
affects activity multiple interactions
EXP
Methylnitronitrosoguanidine affects the activity of EGF protein Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein]; Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
CTD
PMID:15708576
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
G
EGFR
epidermal growth factor receptor
affects localization multiple interactions
EXP
Methylnitronitrosoguanidine affects the localization of EGFR protein Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
CTD
PMID:15708576
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGR1
early growth response 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EGR1 mRNA
CTD
PMID:19840844
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EIF1
eukaryotic translation initiation factor 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of EIF1 mRNA
CTD
PMID:19840844
NCBI chr17:41,688,885...41,692,668
Ensembl chr17:41,688,885...41,692,668
G
EIF3E
eukaryotic translation initiation factor 3 subunit E
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of EIF3E mRNA
CTD
PMID:12634122
NCBI chr 8:108,201,216...108,248,717
Ensembl chr 8:108,162,787...108,443,496
G
EIF5
eukaryotic translation initiation factor 5
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of EIF5 mRNA
CTD
PMID:12634122
NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025
G
EIF5A
eukaryotic translation initiation factor 5A
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EIF5A mRNA
CTD
PMID:19840844
NCBI chr17:7,306,999...7,312,463
Ensembl chr17:7,306,999...7,312,463
G
ELK3
ETS transcription factor ELK3
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of ELK3 mRNA
CTD
PMID:12634122
NCBI chr12:96,194,375...96,269,824
Ensembl chr12:96,194,375...96,269,824
G
EMP1
epithelial membrane protein 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of EMP1 mRNA
CTD
PMID:12634122
NCBI chr12:13,196,726...13,219,941
Ensembl chr12:13,196,723...13,219,941
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of ENPP2 mRNA
CTD
PMID:15120970
NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
G
EPCAM
epithelial cell adhesion molecule
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of EPCAM mRNA
CTD
PMID:12634122
NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601
G
EPHA1
EPH receptor A1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of EPHA1 mRNA
CTD
PMID:12634122
NCBI chr 7:143,391,129...143,408,856
Ensembl chr 7:143,390,289...143,408,856
G
EPHB3
EPH receptor B3
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of EPHB3 mRNA
CTD
PMID:12634122
NCBI chr 3:184,561,785...184,582,408
Ensembl chr 3:184,561,785...184,582,408
G
EPS8
EGFR pathway substrate 8, signaling adaptor
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EPS8 mRNA
CTD
PMID:19840844
NCBI chr12:15,620,134...15,789,388
Ensembl chr12:15,620,134...15,882,329
G
ERBB2
erb-b2 receptor tyrosine kinase 2
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of ERBB2 mRNA
CTD
PMID:12634122
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
G
ERBB4
erb-b2 receptor tyrosine kinase 4
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of ERBB4 mRNA
CTD
PMID:12634122
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
G
ESR2
estrogen receptor 2
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of ESR2 mRNA; Methylnitronitrosoguanidine results in increased expression of ESR2 protein
CTD
PMID:21628965 PMID:22330348
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
ETS1
ETS proto-oncogene 1, transcription factor
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of ETS1 mRNA
CTD
PMID:12634122
NCBI chr11:128,458,765...128,587,558
Ensembl chr11:128,458,761...128,587,558
G
FASLG
Fas ligand
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of FASLG protein
CTD
PMID:24821435
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FASN
fatty acid synthase
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of FASN mRNA
CTD
PMID:12634122
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FAU
FAU ubiquitin like and ribosomal protein S30 fusion
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of FAU mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of FAU mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FAU mRNA
CTD
PMID:19840844
NCBI chr11:65,120,630...65,122,134
Ensembl chr11:65,120,630...65,122,177
G
FCER1A
Fc epsilon receptor Ia
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of FCER1A mRNA
CTD
PMID:15120970
NCBI chr 1:159,283,575...159,308,202
Ensembl chr 1:159,289,714...159,308,224
G
FCGR2A
Fc gamma receptor IIa
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of FCGR3 mRNA
CTD
PMID:15120970
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FCGRT
Fc gamma receptor and transporter
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of FCGRT mRNA
CTD
PMID:12634122
NCBI chr19:49,512,661...49,526,428
Ensembl chr19:49,506,816...49,526,428
G
FES
FES proto-oncogene, tyrosine kinase
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of FES mRNA
CTD
PMID:12634122
NCBI chr15:90,884,504...90,895,776
Ensembl chr15:90,883,695...90,895,776
G
FGF10
fibroblast growth factor 10
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of FGF10 mRNA
CTD
PMID:15120970
NCBI chr 5:44,300,247...44,389,420
Ensembl chr 5:44,300,247...44,389,706
G
FLT1
fms related receptor tyrosine kinase 1
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of FLT1 mRNA]
CTD
PMID:20434464
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
FOLR1
folate receptor alpha
increases methylation
EXP
Methylnitronitrosoguanidine results in increased methylation of FOLR1 promoter
CTD
PMID:29644877
NCBI chr11:72,189,709...72,196,323
Ensembl chr11:72,189,558...72,196,323
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
decreases expression multiple interactions
EXP
Methylnitronitrosoguanidine results in decreased expression of FOSL1 mRNA Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [FOSL1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [FOSL1 protein results in increased expression of RRM2 mRNA]
CTD
PMID:12634122 PMID:26921499
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FST
follistatin
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of FST mRNA
CTD
PMID:15120970
NCBI chr 5:53,480,629...53,487,134
Ensembl chr 5:53,480,626...53,487,134
G
FSTL1
follistatin like 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of FSTL1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of FSTL1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FSTL1 mRNA
CTD
PMID:19840844
NCBI chr 3:120,392,293...120,450,992
Ensembl chr 3:120,392,293...120,451,016
G
FYN
FYN proto-oncogene, Src family tyrosine kinase
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of FYN mRNA
CTD
PMID:12634122
NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452
G
GADD45A
growth arrest and DNA damage inducible alpha
decreases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in decreased expression of GADD45A mRNA Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of GADD45A mRNA]
CTD
PMID:19851710
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GCGR
glucagon receptor
decreases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of GCGR mRNA
CTD
PMID:15120970
NCBI chr17:81,804,150...81,814,008
Ensembl chr17:81,804,132...81,814,008
G
GDF15
growth differentiation factor 15
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of GDF15 mRNA
CTD
PMID:12634122 PMID:12773770
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GJA1
gap junction protein alpha 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of GJA1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GJA1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GJA1 mRNA
CTD
PMID:19840844
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GJB2
gap junction protein beta 2
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of GJB2 mRNA
CTD
PMID:15120970
NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938
G
GLI1
GLI family zinc finger 1
increases expression
ISO
MNNG increases expression of Gli1 mRNA in rat stomach
RGD
PMID:30537251
RGD:150520178
NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
G
GPC4
glypican 4
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of GPC4 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GPC4 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GPC4 mRNA
CTD
PMID:19840844
NCBI chr X:133,300,103...133,415,489
Ensembl chr X:133,300,103...133,415,489
G
GSS
glutathione synthetase
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of GSS mRNA
CTD
PMID:12634122
NCBI chr20:34,928,432...34,956,027
Ensembl chr20:34,928,432...34,956,027
G
GSTM2
glutathione S-transferase mu 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of GSTM2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GSTM2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GSTM2 mRNA
CTD
PMID:19840844
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTO1
glutathione S-transferase omega 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of GSTO1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of GSTO1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GSTO1 mRNA
CTD
PMID:19840844
NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
G
GSTP1
glutathione S-transferase pi 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of GSTP1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of GSTP1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GSTP1 mRNA
CTD
PMID:19840844
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GTF2I
general transcription factor IIi
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [GTF2I protein binds to RRM2 promoter]
CTD
PMID:26921499
NCBI chr 7:74,657,718...74,760,692
Ensembl chr 7:74,650,231...74,760,692
G
H2AX
H2A.X variant histone
multiple interactions increases expression
EXP
[[Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA] inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; E2F3 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; RRM2 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]
CTD
PMID:26921499 PMID:27233451
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
G
H4C2
H4 clustered histone 2
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of H4C2 mRNA
CTD
PMID:12634122
NCBI chr 6:26,026,896...26,027,283
Ensembl chr 6:26,026,896...26,027,283
G
HBA1
hemoglobin subunit alpha 1
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of HBA1 mRNA
CTD
PMID:15120970
NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
G
HIF1A
hypoxia inducible factor 1 subunit alpha
multiple interactions increases expression
ISO
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of HIF1A mRNA]
CTD
PMID:35103375
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of HLA-DRB1 mRNA
CTD
PMID:12634122
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HMGB1
high mobility group box 1
increases expression multiple interactions
EXP ISO
Methylnitronitrosoguanidine results in increased expression of HMGB1 mRNA corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of HMGB1 mRNA]
CTD
PMID:12634122 PMID:35103375
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMGB2
high mobility group box 2
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of HMGB2 mRNA
CTD
PMID:12634122
NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
G
HPGD
15-hydroxyprostaglandin dehydrogenase
decreases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of HPGD mRNA
CTD
PMID:15120970
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
G
HPRT1
hypoxanthine phosphoribosyltransferase 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HPRT1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of HPRT1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HPRT1 mRNA
CTD
PMID:19840844
NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,165...134,520,513
G
HRAS
HRas proto-oncogene, GTPase
multiple interactions
EXP
Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein]
CTD
PMID:15708576
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HSP90AA1 mRNA
CTD
PMID:19840844
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSP90AB1
heat shock protein 90 alpha family class B member 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HSP90AB1 mRNA
CTD
PMID:19840844
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
G
HSP90B1
heat shock protein 90 beta family member 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of HSP90B1 mRNA
CTD
PMID:12634122
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
decreases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of HSPA1A mRNA
CTD
PMID:15120970
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPD1
heat shock protein family D (Hsp60) member 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of HSPD1 mRNA
CTD
PMID:19840844
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
ICAM1
intercellular adhesion molecule 1
decreases response to substance multiple interactions increases expression
EXP
ICAM1 protein results in decreased susceptibility to Methylnitronitrosoguanidine prolinedithiocarbamate inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of ICAM1 protein] Methylnitronitrosoguanidine results in increased expression of ICAM1 mRNA; Methylnitronitrosoguanidine results in increased expression of ICAM1 protein
CTD
PMID:22001597
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ID1
inhibitor of DNA binding 1
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of ID1 mRNA
CTD
PMID:12634122
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
IER3
immediate early response 3
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of IER3 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IER3 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IER3 mRNA
CTD
PMID:19840844
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IFI16
interferon gamma inducible protein 16
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [IFI16 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [IFI16 protein results in increased expression of RRM2 mRNA]
CTD
PMID:26921499
NCBI chr 1:158,999,976...159,055,151
Ensembl chr 1:158,999,968...159,055,155
G
IFITM1
interferon induced transmembrane protein 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of IFITM1 mRNA
CTD
PMID:12634122 PMID:12773770
NCBI chr11:314,040...315,272
Ensembl chr11:310,041...315,272
G
IFRD1
interferon related developmental regulator 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of IFRD1 mRNA
CTD
PMID:12634122
NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
G
IGKC
immunoglobulin kappa constant
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of IGKC mRNA
CTD
PMID:15120970
NCBI chr 2:88,857,361...88,857,683
Ensembl chr 2:88,857,161...88,857,683
G
IGSF6
immunoglobulin superfamily member 6
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of IGSF6 mRNA
CTD
PMID:15120970
NCBI chr16:21,639,550...21,652,608
Ensembl chr16:21,639,550...21,652,608
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of IKBKB protein]
CTD
PMID:19851710
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
G
IRAK1
interleukin 1 receptor associated kinase 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of IRAK1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IRAK1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IRAK1 mRNA
CTD
PMID:19840844
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
G
ITGB4
integrin subunit beta 4
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of ITGB4 mRNA
CTD
PMID:12634122 PMID:12773770
NCBI chr17:75,721,459...75,757,818
Ensembl chr17:75,721,328...75,757,818
G
JMJD6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of JMJD6 mRNA
CTD
PMID:19840844
NCBI chr17:76,712,836...76,726,606
Ensembl chr17:76,712,832...76,726,799
G
JPT1
Jupiter microtubule associated homolog 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of JPT1 mRNA
CTD
PMID:19840844
NCBI chr17:75,135,243...75,154,512
Ensembl chr17:75,135,248...75,168,281
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which results in increased expression of RRM2 mRNA]
CTD
PMID:26921499
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
G
KCTD12
potassium channel tetramerization domain containing 12
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of KCTD12 mRNA
CTD
PMID:15120970
NCBI chr13:76,880,175...76,886,405
Ensembl chr13:76,880,175...76,886,405
G
KDM8
lysine demethylase 8
multiple interactions
EXP
Methylnitronitrosoguanidine inhibits the reaction [TP53 protein binds to KDM8 protein]
CTD
PMID:26025680
NCBI chr16:27,203,526...27,221,768
Ensembl chr16:27,203,508...27,221,768
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of KIT mRNA
CTD
PMID:12634122
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
G
KITLG
KIT ligand
decreases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of KITLG mRNA
CTD
PMID:15120970
NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
G
KLF10
KLF transcription factor 10
decreases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of KLF10 mRNA
CTD
PMID:15120970
NCBI chr 8:102,648,784...102,655,725
Ensembl chr 8:102,648,784...102,655,725
G
KRAS
KRAS proto-oncogene, GTPase
increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in increased expression of KRAS mRNA geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KRAS mRNA]
CTD
PMID:28428697
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
G
KRT17
keratin 17
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of KRT17 mRNA
CTD
PMID:12634122
NCBI chr17:41,619,442...41,624,575
Ensembl chr17:41,619,442...41,624,842
G
LDHA
lactate dehydrogenase A
multiple interactions increases expression
ISO
corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of LDHA mRNA]
CTD
PMID:35103375
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
G
LGALS3
galectin 3
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA
CTD
PMID:19840844
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
LGALS8
galectin 8
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of LGALS8 mRNA
CTD
PMID:12634122
NCBI chr 1:236,518,214...236,552,981
Ensembl chr 1:236,518,000...236,552,981
G
LIG1
DNA ligase 1
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of LIG1 mRNA
CTD
PMID:12634122
NCBI chr19:48,115,445...48,170,344
Ensembl chr19:48,115,445...48,170,603
G
LIPA
lipase A, lysosomal acid type
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of LIP1 mRNA
CTD
PMID:15120970
NCBI chr10:89,213,572...89,251,775
Ensembl chr10:89,213,569...89,414,557
G
LOX
lysyl oxidase
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LOX mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LOX mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LOX mRNA
CTD
PMID:19840844
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LPL
lipoprotein lipase
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LPL mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LPL mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LPL mRNA
CTD
PMID:19840844
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
MAP2K1
mitogen-activated protein kinase kinase 1
increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in increased expression of MAP2K1 mRNA geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MAP2K1 mRNA]
CTD
PMID:28428697
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
G
MAP3K12
mitogen-activated protein kinase kinase kinase 12
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MAP3K12 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MAP3K12 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of MAP3K12 mRNA
CTD
PMID:19840844
NCBI chr12:53,479,669...53,501,539
Ensembl chr12:53,479,669...53,500,063
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation multiple interactions
EXP
Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK1 protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK1 protein]]
CTD
PMID:17828454
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK14
mitogen-activated protein kinase 14
increases phosphorylation
EXP
Methylnitronitrosoguanidine results in increased phosphorylation of MAPK14 protein
CTD
PMID:22001597
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions decreases phosphorylation
EXP
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased phosphorylation of MAPK3 protein]]
CTD
PMID:17828454
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK4
mitogen-activated protein kinase 4
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MAPK4 mRNA
CTD
PMID:12634122
NCBI chr18:50,559,612...50,731,826
Ensembl chr18:50,560,087...50,731,826
G
MAPK8
mitogen-activated protein kinase 8
increases phosphorylation
EXP
Methylnitronitrosoguanidine results in increased phosphorylation of MAPK8 protein
CTD
PMID:22001597
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MAPK9
mitogen-activated protein kinase 9
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MAPK9 mRNA
CTD
PMID:12634122
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
G
MARCKS
myristoylated alanine rich protein kinase C substrate
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of MARCKS mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of MARCKS mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MARCKS mRNA
CTD
PMID:19840844
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
G
MAX
MYC associated factor X
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MAX mRNA
CTD
PMID:12634122
NCBI chr14:65,006,101...65,102,695
Ensembl chr14:65,006,174...65,102,695
G
MCAM
melanoma cell adhesion molecule
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MCAM mRNA
CTD
PMID:12634122 PMID:12773770
NCBI chr11:119,308,529...119,317,130
Ensembl chr11:119,308,529...119,321,521
G
MCM2
minichromosome maintenance complex component 2
decreases expression multiple interactions
EXP ISO
Methylnitronitrosoguanidine results in decreased expression of MCM2 mRNA [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MCM2 mRNA
CTD
PMID:12634122 PMID:19840844
NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,410...127,622,436
G
MCM4
minichromosome maintenance complex component 4
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of MCM4 mRNA
CTD
PMID:12634122
NCBI chr 8:47,960,941...47,978,160
Ensembl chr 8:47,960,185...47,978,160
G
MCM6
minichromosome maintenance complex component 6
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MCM6 mRNA
CTD
PMID:19840844
NCBI chr 2:135,839,626...135,876,443
Ensembl chr 2:135,839,626...135,876,443
G
MDM2
MDM2 proto-oncogene
increases expression multiple interactions
EXP ISO
Methylnitronitrosoguanidine results in increased expression of MDM2 mRNA Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of MDM2 protein]
CTD
PMID:12135628 PMID:12634122
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
MECOM
MDS1 and EVI1 complex locus
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MECOM mRNA
CTD
PMID:12634122
NCBI chr 3:169,083,507...169,663,712
Ensembl chr 3:169,083,499...169,663,775
G
MET
MET proto-oncogene, receptor tyrosine kinase
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MET mRNA
CTD
PMID:12634122
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
MGMT
O-6-methylguanine-DNA methyltransferase
decreases response to substance
EXP ISO
MGMT protein results in decreased susceptibility to Methylnitronitrosoguanidine
CTD
PMID:1727384 PMID:15010311 PMID:16043385
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MGST2
microsomal glutathione S-transferase 2
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of MGST2 mRNA
CTD
PMID:12634122
NCBI chr 4:139,665,819...139,754,618
Ensembl chr 4:139,665,768...139,740,745
G
MGST3
microsomal glutathione S-transferase 3
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MGST3 mRNA
CTD
PMID:19840844
NCBI chr 1:165,631,234...165,656,136
Ensembl chr 1:165,631,213...165,661,796
G
MIR21
microRNA 21
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MIR21 mRNA
CTD
PMID:24821435
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MLH1
mutL homolog 1
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of MLH1 protein
CTD
PMID:17671175
NCBI chr 3:36,993,466...37,050,846
Ensembl chr 3:36,993,226...37,050,896
G
MMP2
matrix metallopeptidase 2
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP2 mRNA]; Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP2 protein [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MMP2 mRNA
CTD
PMID:19840844 PMID:20434464
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA]; Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein
CTD
PMID:20434464
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPG
N-methylpurine DNA glycosylase
increases response to substance
EXP
MPG protein results in increased susceptibility to Methylnitronitrosoguanidine
CTD
PMID:15299078
NCBI chr16:77,007...85,846
Ensembl chr16:77,007...85,851
G
MPP1
MAGUK p55 scaffold protein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of MPP1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of MPP1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MPP1 mRNA
CTD
PMID:19840844
NCBI chr X:154,778,684...154,805,485
Ensembl chr X:154,778,684...154,821,007
G
MSH2
mutS homolog 2
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MSH2 mRNA
CTD
PMID:12634122
NCBI chr 2:47,403,067...47,709,830
Ensembl chr 2:47,403,067...47,663,146
G
MST1
macrophage stimulating 1
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of MST1 mRNA
CTD
PMID:15120970
NCBI chr 3:49,683,947...49,689,474
Ensembl chr 3:49,683,947...49,689,501
G
MT1X
metallothionein 1X
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MT1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MT1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of MT1 mRNA
CTD
PMID:19840844
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
G
MTHFR
methylenetetrahydrofolate reductase
increases methylation
EXP
Methylnitronitrosoguanidine results in increased methylation of MTHFR promoter
CTD
PMID:29644877
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MUTYH
mutY DNA glycosylase
multiple interactions
ISO
MUTYH protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of PARP1 protein]
CTD
PMID:26954031
NCBI chr 1:45,329,242...45,340,440
Ensembl chr 1:45,329,163...45,340,893
G
MYBL1
MYB proto-oncogene like 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MYBL1 mRNA
CTD
PMID:12634122
NCBI chr 8:66,562,175...66,613,218
Ensembl chr 8:66,562,175...66,614,247
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in increased expression of MYC protein Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of MYC protein]
CTD
PMID:12135628
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYL2
myosin light chain 2
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MYL2 mRNA
CTD
PMID:12634122
NCBI chr12:110,910,845...110,921,449
Ensembl chr12:110,910,819...110,921,443
G
MYL9
myosin light chain 9
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of MYL9 mRNA
CTD
PMID:12634122
NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447
G
MYLK
myosin light chain kinase
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of MYLK mRNA
CTD
PMID:12634122
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
NBL1
NBL1, DAN family BMP antagonist
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of NBL1 mRNA
CTD
PMID:12634122
NCBI chr 1:19,643,229...19,658,452
Ensembl chr 1:19,596,979...19,658,456
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein] Methylnitronitrosoguanidine results in increased expression of NFKB1 mRNA; Methylnitronitrosoguanidine results in increased expression of NFKB1 protein
CTD
PMID:19851710
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKBIA
NFKB inhibitor alpha
multiple interactions increases expression decreases expression
ISO EXP
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKBIA protein modified form] Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased degradation of NFKBIA protein Methylnitronitrosoguanidine results in decreased expression of NFKBIA mRNA; Methylnitronitrosoguanidine results in decreased expression of NFKBIA protein
CTD
PMID:19851710 PMID:22001597
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NFYA
nuclear transcription factor Y subunit alpha
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [NFYA protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYA protein results in increased expression of RRM2 mRNA]
CTD
PMID:26921499
NCBI chr 6:41,072,974...41,102,403
Ensembl chr 6:41,072,974...41,102,403
G
NFYB
nuclear transcription factor Y subunit beta
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [NFYB protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYB protein results in increased expression of RRM2 mRNA]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]
CTD
PMID:26921499
NCBI chr12:104,117,086...104,138,210
Ensembl chr12:104,117,086...104,138,241
G
NFYC
nuclear transcription factor Y subunit gamma
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [NFYC protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYC protein results in increased expression of RRM2 mRNA]
CTD
PMID:26921499
NCBI chr 1:40,691,704...40,771,603
Ensembl chr 1:40,691,648...40,771,603
G
NRP1
neuropilin 1
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of NRP1 mRNA
CTD
PMID:15120970
NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262
G
ODC1
ornithine decarboxylase 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of ODC1 mRNA
CTD
PMID:19840844
NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
G
PA2G4
proliferation-associated 2G4
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PA2G4 mRNA
CTD
PMID:19840844
NCBI chr12:56,104,559...56,113,910
Ensembl chr12:56,104,537...56,113,910
G
PARG
poly(ADP-ribose) glycohydrolase
multiple interactions affects response to substance
ISO
[Hydrolyzable Tannins results in decreased activity of PARG protein] which results in decreased susceptibility to Methylnitronitrosoguanidine; [nobotanin B results in decreased activity of PARG protein] which results in decreased susceptibility to Methylnitronitrosoguanidine; benzamide inhibits the reaction [PARG affects the susceptibility to Methylnitronitrosoguanidine]
CTD
PMID:11593040 PMID:15591342
NCBI chr10:49,818,279...49,942,027
Ensembl chr10:49,818,279...49,970,203
G
PARP1
poly(ADP-ribose) polymerase 1
multiple interactions increases expression increases response to substance affects cleavage increases activity
ISO EXP
[benzamide results in decreased activity of PARP1 protein] which results in decreased susceptibility to Methylnitronitrosoguanidine; [Methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of NAD; benzamide inhibits the reaction [[Methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of NAD]; Eugenol affects the reaction [Methylnitronitrosoguanidine affects the cleavage of PARP1 protein]; Hydrolyzable Tannins inhibits the reaction [[Methylnitronitrosoguanidine results in increased activity of PARP1 protein] which results in decreased abundance of NAD]; MUTYH protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of PARP1 protein] PARP1 protein results in increased susceptibility to Methylnitronitrosoguanidine
CTD
PMID:11593040 PMID:20434464 PMID:22001597 PMID:26954031
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PCBP2
poly(rC) binding protein 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PCBP2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PCBP2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCBP2 mRNA
CTD
PMID:19840844
NCBI chr12:53,452,102...53,481,162
Ensembl chr12:53,452,102...53,481,162
G
PCDH7
protocadherin 7
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of PCDH7 mRNA
CTD
PMID:12634122
NCBI chr 4:30,720,369...31,146,800
Ensembl chr 4:30,720,369...31,146,805
G
PCNA
proliferating cell nuclear antigen
decreases expression increases expression multiple interactions
EXP ISO
Methylnitronitrosoguanidine results in decreased expression of PCNA mRNA Methylnitronitrosoguanidine results in increased expression of PCNA mRNA; Methylnitronitrosoguanidine results in increased expression of PCNA protein [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PCNA mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PCNA mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA mRNA; Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of PCNA mRNA]; Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein]; geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein]
CTD
PMID:11516527 PMID:12135628 PMID:12634122 PMID:19840844 PMID:19851710 PMID:22330348 PMID:28428697 More...
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PDGFB
platelet derived growth factor subunit B
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of PDGFB mRNA
CTD
PMID:12634122
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PDGFRA
platelet derived growth factor receptor alpha
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PDGFRA mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PDGFRA mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PDGFRA mRNA
CTD
PMID:19840844
NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245
G
PDIA3
protein disulfide isomerase family A member 3
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PDIA3 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PDIA3 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PDIA3 mRNA
CTD
PMID:19840844
NCBI chr15:43,746,438...43,773,278
Ensembl chr15:43,746,394...43,773,279
G
PEA15
proliferation and apoptosis adaptor protein 15
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of PEA15 mRNA
CTD
PMID:12634122
NCBI chr 1:160,205,384...160,215,372
Ensembl chr 1:160,205,380...160,215,376
G
PGK1
phosphoglycerate kinase 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of PGK1 mRNA
CTD
PMID:12634122
NCBI chr X:78,104,248...78,129,295
Ensembl chr X:77,910,739...78,129,295
G
PGR
progesterone receptor
multiple interactions decreases expression
ISO
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of PGR protein]
CTD
PMID:28428697
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in increased expression of PIK3CG mRNA corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PIK3CG mRNA]
CTD
PMID:35103375
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in increased expression of PIK3R1 mRNA geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PIK3R1 mRNA]
CTD
PMID:28428697
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
G
PLAAT4
phospholipase A and acyltransferase 4
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of PLAAT4 mRNA
CTD
PMID:12634122
NCBI chr11:63,536,808...63,546,458
Ensembl chr11:63,536,808...63,546,462
G
PLXNA3
plexin A3
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of PLXNA3 mRNA
CTD
PMID:12634122
NCBI chr X:154,458,281...154,477,779
Ensembl chr X:154,458,281...154,477,779
G
PODXL
podocalyxin like
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PODXL mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PODXL mRNA
CTD
PMID:19840844
NCBI chr 7:131,500,271...131,556,628
Ensembl chr 7:131,500,262...131,558,217
G
POSTN
periostin
decreases expression
ISO
Methylnitronitrosoguanidine results in decreased expression of POSTN mRNA
CTD
PMID:15120970
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
G
PPP2R2A
protein phosphatase 2 regulatory subunit Balpha
decreases response to substance
EXP
PPP2R2A protein results in decreased susceptibility to Methylnitronitrosoguanidine
CTD
PMID:25772433
NCBI chr 8:26,291,508...26,372,680
Ensembl chr 8:26,291,508...26,372,680
G
PPP2R5C
protein phosphatase 2 regulatory subunit B'gamma
increases response to substance
EXP
PPP2R5C protein results in increased susceptibility to Methylnitronitrosoguanidine
CTD
PMID:25772433
NCBI chr14:101,760,573...101,927,992
Ensembl chr14:101,761,709...101,927,989
G
PPP2R5E
protein phosphatase 2 regulatory subunit B'epsilon
decreases response to substance
EXP
PPP2R5E protein results in decreased susceptibility to Methylnitronitrosoguanidine
CTD
PMID:25772433
NCBI chr14:63,371,364...63,543,377
Ensembl chr14:63,371,364...63,543,377
G
PRKD1
protein kinase D1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of PRKD1 mRNA
CTD
PMID:12634122
NCBI chr14:29,576,479...29,927,847
Ensembl chr14:29,576,479...30,191,898
G
PTEN
phosphatase and tensin homolog
decreases response to substance decreases expression multiple interactions
ISO
PTEN protein results in decreased susceptibility to Methylnitronitrosoguanidine Methylnitronitrosoguanidine results in decreased expression of PTEN protein geraniol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of PTEN protein]
CTD
PMID:20530668 PMID:28428697
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
PTN
pleiotrophin
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PTN mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PTN mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PTN mRNA
CTD
PMID:19840844
NCBI chr 7:137,227,341...137,343,733
Ensembl chr 7:137,227,341...137,343,774
G
PTP4A1
protein tyrosine phosphatase 4A1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of PTP4A1 mRNA
CTD
PMID:12634122
NCBI chr 6:63,516,440...63,583,588
Ensembl chr 6:63,521,746...63,583,588
G
PTPRA
protein tyrosine phosphatase receptor type A
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of PTPRA mRNA
CTD
PMID:12634122
NCBI chr20:2,864,184...3,038,669
Ensembl chr20:2,873,420...3,039,076
G
PTPRG
protein tyrosine phosphatase receptor type G
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of PTPRG mRNA
CTD
PMID:12634122
NCBI chr 3:61,561,571...62,297,609
Ensembl chr 3:61,561,569...62,297,609
G
PTPRS
protein tyrosine phosphatase receptor type S
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of PTPRS mRNA
CTD
PMID:12634122
NCBI chr19:5,205,508...5,340,812
Ensembl chr19:5,158,495...5,340,812
G
PTTG1
PTTG1 regulator of sister chromatid separation, securin
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of PTTG1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of PTTG1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTTG1 mRNA
CTD
PMID:19840844
NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
G
PURA
purine rich element binding protein A
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [PURA protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [PURA protein results in increased expression of RRM2 mRNA]
CTD
PMID:26921499
NCBI chr 5:140,114,109...140,125,619
Ensembl chr 5:140,107,777...140,125,619
G
RACGAP1
Rac GTPase activating protein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RACGAP1 mRNA
CTD
PMID:19840844
NCBI chr12:49,989,162...50,033,440
Ensembl chr12:49,976,923...50,033,136
G
RAD21
RAD21 cohesin complex component
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RAD21 mRNA
CTD
PMID:19840844
NCBI chr 8:116,845,934...116,874,776
Ensembl chr 8:116,845,934...116,874,776
G
RAD23A
RAD23 homolog A, nucleotide excision repair protein
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of RAD23A mRNA
CTD
PMID:12634122 PMID:12773770
NCBI chr19:12,945,862...12,953,642
Ensembl chr19:12,945,855...12,953,642
G
RBBP5
RB binding protein 5, histone lysine methyltransferase complex subunit
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of RBBP5 mRNA
CTD
PMID:12634122
NCBI chr 1:205,086,142...205,121,978
Ensembl chr 1:205,086,142...205,122,015
G
RBM6
RNA binding motif protein 6
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of RBM6 mRNA
CTD
PMID:12634122
NCBI chr 3:49,940,150...50,077,249
Ensembl chr 3:49,940,007...50,100,045
G
RECK
reversion inducing cysteine rich protein with kazal motifs
multiple interactions decreases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK protein] Methylnitronitrosoguanidine results in decreased expression of RECK mRNA; Methylnitronitrosoguanidine results in decreased expression of RECK protein
CTD
PMID:20434464
NCBI chr 9:36,036,913...36,124,455
Ensembl chr 9:36,036,913...36,124,455
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions increases expression
ISO
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein] Methylnitronitrosoguanidine results in increased expression of RELA mRNA; Methylnitronitrosoguanidine results in increased expression of RELA protein
CTD
PMID:19851710
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RELN
reelin
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of RELN mRNA
CTD
PMID:15120970
NCBI chr 7:103,471,789...103,989,658
Ensembl chr 7:103,471,381...103,989,658
G
RGS18
regulator of G protein signaling 18
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of RGS18 mRNA
CTD
PMID:15120970
NCBI chr 1:192,158,462...192,185,815
Ensembl chr 1:192,158,462...192,185,815
G
ROS1
ROS proto-oncogene 1, receptor tyrosine kinase
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of ROS1 mRNA
CTD
PMID:15120970
NCBI chr 6:117,287,353...117,425,942
Ensembl chr 6:117,287,353...117,425,942
G
RPL7
ribosomal protein L7
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of RPL7 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RPL7 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of RPL7 mRNA
CTD
PMID:19840844
NCBI chr 8:73,290,242...73,294,466
Ensembl chr 8:73,290,242...73,295,789
G
RPS11
ribosomal protein S11
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of RPS11 mRNA
CTD
PMID:19840844
NCBI chr19:49,496,434...49,499,708
Ensembl chr19:49,496,365...49,499,708
G
RPS20
ribosomal protein S20
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of RPS20 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RPS20 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of RPS20 mRNA
CTD
PMID:19840844
NCBI chr 8:56,067,254...56,074,506
Ensembl chr 8:56,067,254...56,074,510
G
RPSA
ribosomal protein SA
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of RPSA mRNA
CTD
PMID:12773770
NCBI chr 3:39,406,720...39,412,542
Ensembl chr 3:39,406,716...39,426,255
G
RRM2
ribonucleotide reductase regulatory subunit M2
increases expression multiple interactions
EXP
Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA [[Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA] inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]; [Methylnitronitrosoguanidine results in increased phosphorylation of and results in increased stability of and results in increased expression of E2F3 protein] which results in increased expression of RRM2 mRNA; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; CHEK1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; CHIR-124 inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [[FOSL1 protein binds to JUNB protein] which results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [DP1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [DP1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [FOSL1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [FOSL1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [GTF2I protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [IFI16 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [IFI16 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [NFYA protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYA protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [NFYB protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYB protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [NFYC protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [NFYC protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [PURA protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [PURA protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [RUVBL1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [RUVBL1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine promotes the reaction [YY1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [YY1 protein results in increased expression of RRM2 mRNA]; Methylnitronitrosoguanidine results in increased expression of and affects the localization of RRM2 protein; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein binds to RRM2 promoter]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine promotes the reaction [E2F3 protein results in increased expression of RRM2 mRNA]]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; NFYB protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; RRM2 protein inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of H2AX protein modified form]
CTD
PMID:26921499
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
G
RRM2B
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression multiple interactions affects expression
EXP
Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; E2F1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine results in increased expression of and affects the localization of RRM2B protein; TP53 protein mutant form inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein] Methylnitronitrosoguanidine affects the expression of RRM2B mRNA
CTD
PMID:21704725 PMID:26921499
NCBI chr 8:102,204,501...102,238,961
Ensembl chr 8:102,204,502...102,238,961
G
RUVBL1
RuvB like AAA ATPase 1
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [RUVBL1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [RUVBL1 protein results in increased expression of RRM2 mRNA]
CTD
PMID:26921499
NCBI chr 3:128,064,785...128,153,914
Ensembl chr 3:128,064,778...128,153,914
G
SEC61G
SEC61 translocon subunit gamma
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SEC61G mRNA
CTD
PMID:19840844
NCBI chr 7:54,752,253...54,759,211
Ensembl chr 7:54,752,250...54,759,974
G
SELENOP
selenoprotein P
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of SELENOP mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of SELENOP mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SELENOP mRNA
CTD
PMID:19840844
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
G
SERPINE1
serpin family E member 1
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of SERPINE1 mRNA
CTD
PMID:15120970
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPING1
serpin family G member 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of SERPING1 mRNA
CTD
PMID:12634122
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
G
SLC16A3
solute carrier family 16 member 3
increases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in increased expression of SLC16A3 mRNA corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of SLC16A3 mRNA]
CTD
PMID:35103375
NCBI chr17:82,217,934...82,240,086
Ensembl chr17:82,217,934...82,261,129
G
SMAD2
SMAD family member 2
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of SMAD2 mRNA
CTD
PMID:12634122
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
G
SMO
smoothened, frizzled class receptor
increases expression
ISO
MNNG increases expression of Smo mRNA in rat stomach
RGD
PMID:30537251
RGD:150520178
NCBI chr 7:129,188,633...129,213,545
Ensembl chr 7:129,188,633...129,213,545
G
SNORA62
small nucleolar RNA, H/ACA box 62
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of SNORA62 mRNA
CTD
PMID:12773770
NCBI chr 3:39,411,054...39,411,207
Ensembl chr 3:39,411,054...39,411,206
G
SNRPN
small nuclear ribonucleoprotein polypeptide N
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of SNRPN mRNA
CTD
PMID:12634122
NCBI chr15:24,823,637...24,978,723
Ensembl chr15:24,823,637...24,978,723
G
SPARC
secreted protein acidic and cysteine rich
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of SPARC mRNA
CTD
PMID:12634122
NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
G
SPINK1
serine peptidase inhibitor Kazal type 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of SPINK1 mRNA
CTD
PMID:12634122
NCBI chr 5:147,824,582...147,839,196
Ensembl chr 5:147,824,572...147,831,671
G
SPINT2
serine peptidase inhibitor, Kunitz type 2
decreases expression increases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of SPINT2 mRNA Methylnitronitrosoguanidine results in increased expression of SPINT2 mRNA
CTD
PMID:12634122
NCBI chr19:38,264,573...38,292,615
Ensembl chr19:38,244,035...38,292,615
G
SPP1
secreted phosphoprotein 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of SPP1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SPP1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SPP1 mRNA
CTD
PMID:19840844
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SQLE
squalene epoxidase
increases expression multiple interactions
EXP ISO
Methylnitronitrosoguanidine results in increased expression of SQLE mRNA [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SQLE mRNA
CTD
PMID:12634122 PMID:19840844
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
G
SRSF7
serine and arginine rich splicing factor 7
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of SRSF7 mRNA
CTD
PMID:12634122
NCBI chr 2:38,743,599...38,751,494
Ensembl chr 2:38,743,599...38,751,494
G
STK39
serine/threonine kinase 39
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of STK39 mRNA
CTD
PMID:12634122
NCBI chr 2:167,954,022...168,247,595
Ensembl chr 2:167,954,020...168,247,595
G
SUFU
SUFU negative regulator of hedgehog signaling
decreases expression
ISO
MNNG decreases expression of Sufu mRNA in rat stomach
RGD
PMID:30537251
RGD:150520178
NCBI chr10:102,502,819...102,633,535
Ensembl chr10:102,503,972...102,633,535
G
SUMO2
small ubiquitin like modifier 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of SUMO2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SUMO2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SUMO2 mRNA
CTD
PMID:19840844
NCBI chr17:75,165,586...75,182,959
Ensembl chr17:75,165,586...75,182,959
G
SYN1
synapsin I
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of SYN1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of SYN1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SYN1 mRNA
CTD
PMID:19840844
NCBI chr X:47,571,901...47,619,857
Ensembl chr X:47,571,901...47,619,857
G
TBRG4
transforming growth factor beta regulator 4
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of TBRG4 mRNA
CTD
PMID:12634122
NCBI chr 7:45,100,100...45,111,697
Ensembl chr 7:45,100,100...45,112,047
G
TGFB1
transforming growth factor beta 1
multiple interactions increases expression
ISO
geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TGFB1 mRNA]
CTD
PMID:28428697
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
THBS1
thrombospondin 1
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of THBS1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of THBS1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of THBS1 mRNA
CTD
PMID:19840844
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
THBS2
thrombospondin 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of THBS2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of THBS2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of THBS2 mRNA
CTD
PMID:19840844
NCBI chr 6:169,215,785...169,253,846
Ensembl chr 6:169,215,780...169,254,050
G
TIAM1
TIAM Rac1 associated GEF 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of TIAM1 mRNA
CTD
PMID:12634122
NCBI chr21:31,118,418...31,559,087
Ensembl chr21:31,118,416...31,559,977
G
TIMP2
TIMP metallopeptidase inhibitor 2
decreases expression multiple interactions
ISO
Methylnitronitrosoguanidine results in decreased expression of TIMP2 mRNA; Methylnitronitrosoguanidine results in decreased expression of TIMP2 protein [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of TIMP2 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of TIMP2 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of TIMP2 mRNA Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 protein]
CTD
PMID:19840844 PMID:20434464
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TLR4
toll like receptor 4
increases expression
ISO
Methylnitronitrosoguanidine results in increased expression of TLR4 mRNA
CTD
PMID:15120970
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TMSB4X
thymosin beta 4 X-linked
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TMSB4X mRNA
CTD
PMID:19840844
NCBI chr X:12,975,110...12,977,223
Ensembl chr X:12,975,110...12,977,227
G
TNC
tenascin C
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of TNC mRNA
CTD
PMID:12634122
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNFRSF25
TNF receptor superfamily member 25
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of TNFRSF25 mRNA
CTD
PMID:12634122
NCBI chr 1:6,460,786...6,466,173
Ensembl chr 1:6,460,786...6,466,175
G
TOP2A
DNA topoisomerase II alpha
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TOP2A mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TOP2A mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TOP2A mRNA
CTD
PMID:19840844
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
G
TP53
tumor protein p53
increases expression multiple interactions decreases expression increases acetylation increases response to substance decreases response to substance
EXP ISO
Methylnitronitrosoguanidine results in increased expression of TP53 mRNA; Methylnitronitrosoguanidine results in increased expression of TP53 protein ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein]; Methylnitronitrosoguanidine inhibits the reaction [TP53 protein binds to KDM8 protein]; TP53 protein mutant form inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein] Methylnitronitrosoguanidine results in increased expression of TRP53 protein [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TRP53 mRNA; Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TRP53 protein] Methylnitronitrosoguanidine results in decreased expression of TP53 protein Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TP53 protein]; resveratrol inhibits the reaction [Methylnitronitrosoguanidine results in increased acetylation of TP53 protein] TP53 protein results in increased susceptibility to Methylnitronitrosoguanidine TP53 protein mutant form results in decreased susceptibility to Methylnitronitrosoguanidine
CTD
PMID:9667752 PMID:11516527 PMID:12135628 PMID:12634122 PMID:15589979 PMID:17147953 PMID:19851710 PMID:26025680 PMID:26921499 More...
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TRAM1
translocation associated membrane protein 1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of TRAM1 mRNA
CTD
PMID:12634122
NCBI chr 8:70,573,218...70,608,416
Ensembl chr 8:70,573,218...70,608,416
G
TSC22D1
TSC22 domain family member 1
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of TSC22D1 mRNA
CTD
PMID:12634122
NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,147
G
TTC3
tetratricopeptide repeat domain 3
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of TTC3 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of TTC3 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of TTC3 mRNA
CTD
PMID:19840844
NCBI chr21:37,073,254...37,203,118
Ensembl chr21:37,073,226...37,203,112
G
TXN
thioredoxin
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of TXN1 mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of TXN1 mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TXN1 mRNA
CTD
PMID:19840844
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
UBC
ubiquitin C
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of UBC mRNA; [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of UBC mRNA; [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of UBC mRNA
CTD
PMID:19840844
NCBI chr12:124,911,646...124,914,650
Ensembl chr12:124,911,604...124,917,368
G
UCHL1
ubiquitin C-terminal hydrolase L1
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of UCHL1 mRNA
CTD
PMID:12634122
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
G
UCP2
uncoupling protein 2
multiple interactions
ISO
[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of UCP2 mRNA
CTD
PMID:19840844
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843
G
VIM
vimentin
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of VIM mRNA
CTD
PMID:12634122 PMID:12773770
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
WARS1
tryptophanyl-tRNA synthetase 1
decreases expression
EXP
Methylnitronitrosoguanidine results in decreased expression of WARS1 mRNA
CTD
PMID:12634122
NCBI chr14:100,333,790...100,376,327
Ensembl chr14:100,333,790...100,376,805
G
WNT2
Wnt family member 2
increases expression
EXP
Methylnitronitrosoguanidine results in increased expression of WNT2 mRNA
CTD
PMID:12634122
NCBI chr 7:117,275,451...117,323,058
Ensembl chr 7:117,275,451...117,323,152
G
YY1
YY1 transcription factor
multiple interactions
EXP
Methylnitronitrosoguanidine promotes the reaction [YY1 protein binds to RRM2 promoter]; Methylnitronitrosoguanidine promotes the reaction [YY1 protein results in increased expression of RRM2 mRNA]
CTD
PMID:26921499
NCBI chr14:100,239,144...100,282,788
Ensembl chr14:100,238,298...100,282,788
G
ALPL
alkaline phosphatase, biomineralization associated
multiple interactions increases activity
ISO
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of ALPL protein] Thiamethoxam results in increased activity of ALPL protein
CTD
PMID:30621503
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
G
ANXA10
annexin A10
increases expression
EXP
Thiamethoxam results in increased expression of ANXA10 mRNA
CTD
PMID:32194361
NCBI chr 4:168,092,537...168,187,736
Ensembl chr 4:168,092,537...168,187,736
G
AR
androgen receptor
affects binding
EXP
Thiamethoxam binds to AR protein
CTD
PMID:31550567
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ARG1
arginase 1
decreases expression
EXP
Thiamethoxam results in decreased expression of ARG1 mRNA
CTD
PMID:32194361
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ATF3
activating transcription factor 3
increases expression
ISO
Thiamethoxam results in increased expression of ATF3 mRNA
CTD
PMID:33533595
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
ISO
Thiamethoxam results in increased expression of BAX protein
CTD
PMID:33533595
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
decreases expression
ISO
Thiamethoxam results in decreased expression of BCL2 protein
CTD
PMID:33533595
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL6
BCL6 transcription repressor
decreases expression
ISO
Thiamethoxam results in decreased expression of BCL6 mRNA
CTD
PMID:33533595
NCBI chr 3:187,721,377...187,745,468
Ensembl chr 3:187,721,377...187,745,725
G
BTG1
BTG anti-proliferation factor 1
increases expression
ISO
Thiamethoxam results in increased expression of BTG1 mRNA
CTD
PMID:33533595
NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
G
CASP3
caspase 3
increases cleavage
ISO
Thiamethoxam results in increased cleavage of CASP3 protein
CTD
PMID:33533595
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CAT
catalase
increases expression decreases expression decreases activity multiple interactions
ISO
Thiamethoxam results in increased expression of CAT mRNA Thiamethoxam results in decreased expression of CAT mRNA Thiamethoxam results in decreased activity of CAT protein [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of CAT mRNA]
CTD
PMID:30621503 PMID:33533595 PMID:34181816 PMID:36958429
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL2
C-C motif chemokine ligand 2
increases expression
ISO
Thiamethoxam results in increased expression of CCL2 mRNA
CTD
PMID:33533595
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO
thiamethoxam results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein]
CTD
PMID:16981889
NCBI chr 1:154,567,778...154,580,013
Ensembl chr 1:154,567,778...154,580,013
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
ISO
Thiamethoxam results in increased expression of CXCL5 mRNA
CTD
PMID:33533595
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
decreases expression multiple interactions
ISO
Thiamethoxam results in decreased expression of CYP11A1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP11A1 mRNA]
CTD
PMID:34181816
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
multiple interactions decreases expression
ISO
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP17A1 mRNA]
CTD
PMID:34181816
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
increases expression multiple interactions increases activity
EXP ISO
thiamethoxam results in increased expression of CYP19A1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of CYP19A1 mRNA] thiamethoxam results in increased activity of CYP19A1 protein
CTD
PMID:26464060 PMID:28750898 PMID:34181816
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
decreases expression
EXP
Thiamethoxam results in decreased expression of CYP2C19 protein
CTD
PMID:32194361
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
multiple interactions
EXP
[NADP co-treated with CYP3A4 protein] results in increased activity of thiamethoxam
CTD
PMID:16153789
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP3A7
cytochrome P450 family 3 subfamily A member 7
increases expression multiple interactions
EXP
thiamethoxam results in increased expression of CYP3A7 Estriol inhibits the reaction [thiamethoxam results in increased expression of CYP3A7]
CTD
PMID:28750898
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
Thiamethoxam results in decreased expression of CYP7A1 protein
CTD
PMID:32194361
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
DDIT3
DNA damage inducible transcript 3
increases expression
ISO
Thiamethoxam results in increased expression of DDIT3 mRNA; Thiamethoxam results in increased expression of DDIT3 protein
CTD
PMID:33533595
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
ESR1
estrogen receptor 1
affects binding decreases expression
EXP ISO
Thiamethoxam binds to ESR1 protein Thiamethoxam results in decreased expression of ESR1 protein
CTD
PMID:31550567 PMID:33533595
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
FOXO3
forkhead box O3
increases expression
ISO
Thiamethoxam results in increased expression of FOXO3 mRNA
CTD
PMID:33533595
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
G
FSHR
follicle stimulating hormone receptor
decreases expression
ISO
Thiamethoxam results in decreased expression of FSHR protein
CTD
PMID:33533595
NCBI chr 2:48,962,157...49,154,515
Ensembl chr 2:48,962,157...49,154,527
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Thiamethoxam results in decreased expression of G6PC1 mRNA
CTD
PMID:32194361
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
GADD45B
growth arrest and DNA damage inducible beta
decreases expression
ISO
Thiamethoxam results in decreased expression of GADD45B mRNA
CTD
PMID:33533595
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GOT1
glutamic-oxaloacetic transaminase 1
multiple interactions increases activity
ISO
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GOT1 protein] Thiamethoxam results in increased activity of GOT1 protein
CTD
PMID:30621503
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
GPT
glutamic--pyruvic transaminase
decreases activity
ISO
thiamethoxam results in decreased activity of GPT protein
CTD
PMID:29197058
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX1
glutathione peroxidase 1
increases expression decreases expression decreases activity multiple interactions
ISO
Thiamethoxam results in increased expression of GPX1 mRNA Thiamethoxam results in decreased expression of GPX1 mRNA Thiamethoxam results in decreased activity of GPX1 protein [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GPX1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of GPX1 mRNA]
CTD
PMID:30621503 PMID:33533595 PMID:36958429
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
HSD3B1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
multiple interactions decreases expression
ISO
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of HSD3B1 mRNA]
CTD
PMID:34181816
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
Thiamethoxam results in increased expression of HSPA5 mRNA; Thiamethoxam results in increased expression of HSPA5 protein
CTD
PMID:33533595
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
IL1B
interleukin 1 beta
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL1B protein] Thiamethoxam results in increased expression of IL1B mRNA; Thiamethoxam results in increased expression of IL1B protein
CTD
PMID:36958429
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL6 mRNA]
CTD
PMID:36958429
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
decreases expression
ISO
Thiamethoxam results in decreased expression of ITPR1 mRNA
CTD
PMID:33533595
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
Thiamethoxam results in decreased expression of JUNB mRNA
CTD
PMID:33533595
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
G
LDHA
lactate dehydrogenase A
multiple interactions increases activity
ISO
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of LDHA protein] Thiamethoxam results in increased activity of LDHA protein
CTD
PMID:30621503
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
G
LHCGR
luteinizing hormone/choriogonadotropin receptor
decreases expression multiple interactions increases expression
ISO
Thiamethoxam results in decreased expression of LHCGR protein Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of LHCGR mRNA]
CTD
PMID:33533595 PMID:34181816
NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
G
LST1
leukocyte specific transcript 1
increases expression
ISO
Thiamethoxam results in increased expression of LST1 mRNA
CTD
PMID:33533595
NCBI chr 6:31,586,277...31,588,909
Ensembl chr 6:31,586,124...31,588,909
G
MC4R
melanocortin 4 receptor
decreases expression
ISO
Thiamethoxam results in decreased expression of MC4R mRNA
CTD
PMID:33533595
NCBI chr18:60,371,062...60,372,775
Ensembl chr18:60,371,062...60,372,775
G
MMP7
matrix metallopeptidase 7
increases expression
ISO
Thiamethoxam results in increased expression of MMP7 mRNA
CTD
PMID:33533595
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
NOS2
nitric oxide synthase 2
multiple interactions increases expression decreases activity
ISO
[thiamethoxam metabolite results in decreased activity of NOS2 protein] which results in increased chemical synthesis of Formaldehyde Thiamethoxam results in increased expression of NOS2 mRNA Silymarin inhibits the reaction [Thiamethoxam results in increased expression of NOS2 mRNA]
CTD
PMID:29197058 PMID:36958429
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PLCG2
phospholipase C gamma 2
decreases expression
ISO
Thiamethoxam results in decreased expression of PLCG2 mRNA
CTD
PMID:33533595
NCBI chr16:81,779,291...81,962,685
Ensembl chr16:81,779,279...81,962,685
G
PRNP
prion protein (Kanno blood group)
increases expression
ISO
Thiamethoxam results in increased expression of PRNP mRNA
CTD
PMID:33533595
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Thiamethoxam results in decreased expression of PTGS2 mRNA
CTD
PMID:33533595
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTHLH
parathyroid hormone like hormone
decreases expression
ISO
Thiamethoxam results in decreased expression of PTHLH mRNA
CTD
PMID:33533595
NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733
G
PTX3
pentraxin 3
increases expression
ISO
Thiamethoxam results in increased expression of PTX3 mRNA
CTD
PMID:33533595
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
G
S100P
S100 calcium binding protein P
increases expression
EXP
Thiamethoxam results in increased expression of S100P mRNA
CTD
PMID:32194361
NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
G
SCARB1
scavenger receptor class B member 1
decreases expression multiple interactions
ISO
Thiamethoxam results in decreased expression of SCARB1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of SCARB1 mRNA]
CTD
PMID:34181816
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SESN2
sestrin 2
increases expression
ISO
Thiamethoxam results in increased expression of SESN2 mRNA
CTD
PMID:33533595
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
G
SLC22A2
solute carrier family 22 member 2
decreases activity
EXP
Thiamethoxam results in decreased activity of SLC22A2 protein
CTD
PMID:31364238
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
G
SLC7A11
solute carrier family 7 member 11
increases expression
ISO
Thiamethoxam results in increased expression of SLC7A11 mRNA
CTD
PMID:33533595
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SOD1
superoxide dismutase 1
decreases activity decreases expression multiple interactions
ISO
Thiamethoxam results in decreased activity of SOD1 protein Thiamethoxam results in decreased expression of SOD1 mRNA [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of SOD1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of SOD1 mRNA]
CTD
PMID:30621503 PMID:36958429
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
STAR
steroidogenic acute regulatory protein
multiple interactions decreases expression
ISO
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of STAR mRNA]
CTD
PMID:34181816
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
G
STC2
stanniocalcin 2
increases expression
ISO
Thiamethoxam results in increased expression of STC2 mRNA
CTD
PMID:33533595
NCBI chr 5:173,314,723...173,328,414
Ensembl chr 5:173,314,723...173,328,447
G
THBS4
thrombospondin 4
decreases expression
ISO
Thiamethoxam results in decreased expression of THBS4 mRNA
CTD
PMID:33533595
NCBI chr 5:79,991,332...80,083,287
Ensembl chr 5:79,991,311...80,083,287
G
THRA
thyroid hormone receptor alpha
affects binding
EXP
Thiamethoxam binds to THRA protein
CTD
PMID:31550567
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
G
TNF
tumor necrosis factor
increases expression multiple interactions
ISO
Thiamethoxam results in increased expression of TNF mRNA; Thiamethoxam results in increased expression of TNF protein Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF mRNA]; Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF protein]
CTD
PMID:36958429
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNNT2
troponin T2, cardiac type
increases secretion multiple interactions
ISO
Thiamethoxam results in increased secretion of TNNT2 protein fenugreek seed meal inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]; Polysaccharides inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]
CTD
PMID:30520268
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all